Volume 11, Issue 1 (Feb 2026)                   JNFS 2026, 11(1): 1-25 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Najafi A, Sasanfar B, Toorang F, Taftian M, Ahmadi Vasmehjani A, Motallaei M et al . Association between Index of Nutritional Quality (INQ) and Severity of Coronary Artery Disease: A Cross-Sectional Study of Patients Undergoing Coronary Angiography. JNFS 2026; 11 (1) :1-25
URL: http://jnfs.ssu.ac.ir/article-1-1311-en.html
School of Nutrition and Food Sciences، Shiraz University of Medical Sciences, Shiraz, Iran.
Full-Text [PDF 2159 kb]   (76 Downloads)     |   Abstract (HTML)  (596 Views)
Full-Text:   (33 Views)
Association between Index of Nutritional Quality (INQ) and Severity of Coronary Artery Disease: A Cross-Sectional Study of Patients Undergoing Coronary Angiography

AmirHossein Najafi; MSc1-3, Bahareh Sasanfar; PhD4, Fatemeh Toorang; PhD5, Marzieh Taftian; MSc1,2,
Azam Ahmadi Vasmehjani; PhD1,2, Maryam Motallaei; MSc1,2 & Amin Salehi-Abargouei; PhD6-7*

1 Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran; 2 Research Center for Food Hygiene and Safety, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran; 3 Student Research Committee, Shahid Sadoughi University of Medical Sciences, Yazd, Iran; 4 Minimally Invasive Surgery Research, Center, Iran University of Medical Sciences, Tehran, Iran; 5 Departments of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; 6 Nutrition Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; 7 School of Nutrition and Food Sciences، Shiraz University of Medical Sciences, Shiraz, Iran.
ARTICLE INFO ABSTRACT
ORIGINAL  ARTICLE Background: Coronary artery disease (CAD) is the predominant form of cardiovascular disease (CVD) and a major cause of mortality globally. This study aimed to investigate the association between the Index of Nutritional Quality (INQ) for specific nutrients and coronary artery stenosis severity, lipid profiles, and body composition in patients undergoing coronary angiography. Methods: In this cross-sectional study of 612 adults (35-75 years) undergoing coronary angiography, dietary intake was assessed using a validated 178-item food frequency questionnaire (FFQ). The INQ was calculated for various nutrients. Coronary artery stenosis was quantified using Gensini (GS) and SYNTAX (SS) scores. Results: A higher INQ for linolenic acid was significantly associated with lower odds of vascular occlusion based on SS after full adjustment (OR=0.5; 95% CI: 0.28-0.88). A higher INQ for fiber was associated with lower total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C), while a higher INQ for protein was associated with elevated high-density lipoprotein cholesterol (HDL-C). Conversely, a higher INQ for riboflavin and vitamin D was correlated with increased TC. A higher INQ for vitamin B6 was linked to increased TC, triglycerides (TG), and visceral fat, but a lower body mass index (BMI). Conclusion: These findings suggest that the quality of nutrient intake, particularly higher linolenic acid and fiber, is associated with a better cardiometabolic
profile and reduced coronary stenosis, highlighting the potential importance of nutrient quality assessment in the dietary management of CAD. Prospective studies are needed to confirm these findings.
Article history:
Received: 6 Apr 2025
Revised: 26 Jul 2025
Accepted: 21 Aug 2025
*Corresponding author:
Amin Salehi-Abargouei, Ph.D. in Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Razi Blvd. Shiraz, Iran, PO Code 7153675541,
Tel: +98-71-317267056,
Fax: +98-71-37257288,
Email: abargouei@sums.ac.ir,
Alternate email: abargouei@gmail.com
Keywords:
Coronary artery disease;
Index of nutritional quality; INQ; Body composition;
Lipid profile


Introduction
Coronary artery disease (CAD) is a heart condition that results from the narrowing or blockage of the coronary arteries by atherosclerotic plaques. This reduces the blood and oxygen supply to the heart muscle, causing ischemia and hypoxia. CAD is the most common type of cardiovascular disease (CVD) and a leading cause of death in both developed and developing countries (Aboyans and Causes of Death Collaborators, 2015, Dalen et al., 2014, Yang et al., 2016). CAD risk factors are generally divided into two categories: non-modifiable risk factors, including age, gender, race, and family history (Hajar, 2017, Pencina et al., 2019), and modifiable risk factors, including obesity, smoking, sedentary lifestyle, and poor diet  ADDIN EN.CITE.DATA (Ades and Savage, 2017, Alexander, 1995, Anand et al., 2015, Arnett et al., 2019, Bechthold et al., 2019, DiNicolantonio and OKeefe, 2017, Malakar et al., 2019, Mons et al., 2015, Mozaffarian et al., 2015, Mozaffarian et al., 2006, Narain et al., 2016, Yusuf et al., 2004). A healthy diet has been mentioned as the main cornerstone of CVD prevention (Perk et al., 2012).
The association between diet quality and macro-micro nutrients and chronic diseases, such as CVD, has been extensively investigated (Coulston, 2001). The observational studies have led to conflicting results regarding the relationship between dietary nutrients and CVD risk factors (Daneshzad et al., 2019, Mohamadi et al., 2023, Sepandi et al., 2022). Previous meta-analyses found inconsistent results regarding the association between CVD risk and dietary carbohydrates (Jo and Park, 2023, Mohammadifard et al., 2022) or protein intake (Naghshi et al., 2020, Qi and Shen, 2020). Furthermore, some meta-analyses have shown that higher dietary intake of folate, vitamin B6, and fiber are associated with a lower risk of CHD (Jayedi and Zargar, 2019, Threapleton et al., 2013, Wu et al., 2015). Although previous investigations have looked into the connection between numerous nutrients and the risk of cardiovascular diseases, there is a lack of studies that evaluate nutrient consumption with regard to recommended dietary allowance (RDA), like the index of nutritional quality (INQ), and their association with a range of health outcomes (Jayedi and Zargar, 2019, Qi and Shen, 2020, Wen et al., 2023, Wu et al., 2015, Zhou et al., 2023). This index is a method that can analyze single foods, meals, and diets quantitatively and qualitatively. The INQ for each nutrient is determined from the ratio of food intake to the RDAs of the same food (Sorenson et al., 1976).
Two cross-sectional studies on the same population (360 Iranian adult women) showed that increasing the INQ of biotin has an inverse association with high-density lipoprotein cholesterol (HDL-C) levels, while increasing the INQ of vitamin B6 was directly associated with serum triglyceride (TG) levels. The level of fasting blood sugar (FBS) reduces as the INQ of vitamin A, magnesium, phosphorus, zinc, and vitamin K increases (Abbas Torki et al., 2022, Alami et al., 2022). A case-control study on Iranian adolescent boys was conducted with 214 overweight or obese subjects as cases and 321 subjects with normal weight as the control group; it showed that obesity has an inverse relationship with INQ of vitamin C, B6, B5, selenium, and magnesium, and with INQ of zinc; it was directly related (Gholamalizadeh et al., 2021). A cross-sectional study on 6248 overweight or obese Iranian adults showed that INQ of iron, B6, folate, zinc, magnesium, calcium, vitamin C, and E has an inverse relationship with overweight and obesity. Also, an inverse relationship exists between the INQ of B1 and B2 with overweight (Jalali et al., 2022).
To the authors’ knowledge, no research has been conducted on the link between the INQ of specific nutrients and the degree of vascular occlusion using the Gensini score (GS) and the Syntax score (SS), lipid profile, FBS, and body composition factors in adults undergoing angiography. Therefore, this study explores the relationship between INQ of carbohydrates, fiber, linoleic acid, linolenic acid, protein, riboflavin, vitamin B6, choline, vitamin D, and zinc with the outcomes above.
Materials and Methods
Participants
This cross-sectional study was conducted on 720 adults between 35 and 75 who were referred to Afshar Hospital, Yazd, Iran, and were willing to participate in the study. Exclusion criteria included: 1) history of cancer, chronic heart failure, history of myocardial infection (MI), percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), chronic kidney disease stage 3 and above, specific liver disease or recipient medicines for those with specific cognitive or psychological disorders, immunodeficiency, AIDS, 2) morbid obesity [body mass index (BMI)> 40 kg/m2], 3) pregnancy or lactation for women, 4) restriction of food intake by mouth for any reason. Individuals with an average daily energy intake of less than 800 or more than 5500 kcal were excluded from the study (n=67). Finally, 653 subjects remained for the current analysis. The protocol and information of this study, with details of time, method, and sample size, were already published (Motallaei et al., 2023).
Coronary artery stenosis assessment
Two scoring systems, the GS and SS, were used to measure the amount and severity of CAD. These scoring systems measure the number of vessels with blockage, the severity of vessel blockage, and the degree to which blockage affects vascular function (Neeland et al., 2012). A detailed description of the classification method of these scores is provided elsewhere (Arabi et al., 2024).
Assessment of dietary intake and INQ
The researchers collected information about the participants' food intake over the past year (Before coronary angiography) through a validated 178-item semi-quantitative food frequency questionnaire (FFQ) (Zimorovat et al., 2022b). The questionnaire asked about the frequency and amount of consumption of various food items daily, weekly, monthly, and yearly. The daily intake values were then converted into grams based on household measures (Zimorovat et al., 2022a). After that, dietary food intakes were converted to dietary nutrients using the United States Department of Agriculture (USDA) food database (USDA, 2018). For each nutrient, the INQ is obtained from the ratio of the daily intake of that nutrient per 1000 kcal intake to the RDA of the same nutrient per 1000 kcal (Sorenson et al., 1976). Adequate Intake (AI) was used if the RDA was not defined for a nutrient (Abbas Torki et al., 2022).
Anthropometric, body composition, and physical activity measurement
A trained nutritionist used a digital scale with an accuracy of 100 grams (Omron, model: BF51) to measure the body weight of the person wearing minimal clothing without shoes. Height was measured using a tape measure with an accuracy of 0.1 cm while standing next to the wall and without shoes. The shoulders were in a normal position, and the head was placed in the horizontal position. To calculate the BMI, weight in kilograms was divided by the square of the height in meters. Waist circumference was measured using an inflexible tape measure, between the iliac bone and the last rib above the pelvis, while the participant was standing. The measurement was taken just below the last rib, and the tape was tight enough in all the measurements (Wang et al., 2003). Body fat percentage, skeletal muscle percentage, and visceral fat percentage were measured using a digital scale with bioimpedance (Omron, model: BF51). Also, daily physical activity was evaluated using the International Physical Activity Questionnaire (IPAQ). (Pate et al., 1995).
Biochemical parameters
Total cholesterol (TC), TG, low-density lipoprotein cholesterol (LDL-C), HDL-C, and FBS were evaluated using their last blood test before coronary angiography. If a person has yet to undergo relevant tests, the blood sample provided to the research team with prior consent was used. The methods and procedures of using the kits employed in this study have been described in detail in the previous study (Arabi et al., 2024).
Other variables
The study participants were asked to provide information related to their age, gender, level of education, economic status, smoking habits, history of diseases in their first-degree family, use of drugs and supplements, menopause status (for women), and receipt of disease-prevention medications. This information was collected through a demographic questionnaire.
Ethical considerations
This study was conducted according to the guidelines of the Declaration of Helsinki, and all procedures involving human subjects/patients were approved by Shahid Sadoughi University of Medical Sciences. Moreover, written informed consent was obtained from all subjects/patients.
Data analysis
The authors employed the Kolmogorov-Smirnov test to assess normality. Chi-square and Independent t-tests were used to compare qualitative and quantitative variables between different groups. To compare the average INQ of nutrients with GS and SS and the average tertiles of INQ with lipid profile, FBS, and body composition factor, they used the Analysis of Covariance (ANCOVA). Binary logistic regression was used to calculate the odds ratio (OR) and 95% confidence interval after multivariable adjustment. The analyses were first adjusted for age, energy, and sex in the first model, and additionally, for married, menopausal status, physical activity, economic status, job, educational level, smoking, drug addiction, diabetes, and BMI in model 2. Additionally, the authors utilized a fully adjusted multivariable linear regression model for the association between INQ of various nutrients and cardiometabolic indices. Statistical data analysis was performed using IBM SPSS software version 26, and a P-value< 0.05 was considered significant.
Results
The final analysis of this cross-sectional study was performed on 612 participants undergoing coronary angiography separately for GS and SS, as shown in Table 1. Participants with higher scores of GS and SS were older and had lower BMI than those with lower scores (P<0.05). There was a significant difference in the frequency of gender, occupation, menopausal status, smoking, and drug use in GS and SS groups (P<0.05), as well as economic status within the GS subgroups (P<0.05).
An INQ for every nutrient is provided in Table 2. This table indicates that individuals with lower GS and SS scores have higher INQs for linoleic acid, linolenic acid, magnesium, and zinc, while lower INQs are found for iron. Compared to individuals with higher scores of SS, healthy individuals have a higher INQ of manganese to SS, and with higher scores of GS, they have a higher INQ of fiber (P<0.05).
Multivariable-adjusted odds ratios and 95% CIs for GS and SS scores across tertile categories of INQ in crude and adjusted models are presented in Table 3. Individuals with higher scores of INQ for fiber, linoleic acid, protein, riboflavin, and zinc showed a significantly lower probability of vascular occlusion based on GS and SS in the crude model. Nevertheless, no significant association was shown after adjusting for possible confounding variables. A higher INQ of linolenic acid was significantly associated with a lower probability of vascular occlusion based on the GS and SS indices in the crude model (P<0.05). This association remained significant after full adjustment for SS (OR=0.5; 95% CI: 0.28-0.88, P=0.03) in model 2. Individuals in the third tertile of INQ had a lower risk of vascular occlusion based on the GS (OR=0.53; 95% CI: 0.29-0.94) compared with those in the first tertile. As per GS, the crude model exhibited a stronger association between the INQ of choline and a lower OR; however, the adjusted models did not demonstrate this association. Furthermore, there was no significant relationship between the INQ of vitamin D and the probability of vascular occlusion in the crude model. However, in model 1, a higher INQ of vitamin D was associated with a lower risk of atherosclerosis. According to SS, a higher INQ of vitamin B6 was associated with a lower OR in the crude model, but no such association was found in models 1 and 2. The significant association between INQ of Linolenic acid and GS and SS is illustrated in the finalized model in Figure 1.
Table 4 shows the relationship between the category of INQ score for each nutrient and the mean levels of TC, TG, LDL-C, HDL-C, and FBS among all populations and subgroups stratified by diabetes status. In crude and adjusted models for all subjects, higher INQ of fiber was shown to have a significant association with lower TC, and higher INQ of vitamin B6 was shown to have a significant association with higher TC. Furthermore, a significant association between higher INQ of riboflavin and vitamin D and higher TC was observed in the adjusted model. In the subgroup of diabetics, it was shown that in the crude model, there is a significant association between a higher INQ of fiber and a lower TC. In the non-diabetic subgroup, there is an inverse relationship with TC the higher the fiber INQ in the crude and adjusted models. Furthermore, a higher INQ of riboflavin has a significant and direct association with TC level. A significant association was shown between higher INQ of vitamin B6 and higher TG, and higher INQ of fiber and lower LDL-C in all populations and the subgroup of non-diabetics. In all populations and the subgroup of non-diabetics, a significant association was found between higher INQ of protein and higher HDL-C in the crude and remained significant after adjustment for confounders. Compared to the first tertile, the population in the second tertile of INQ of linoleic acid had higher levels of HDL-C. In the non-diabetic subgroup and the adjusted model, there was a significant association between higher protein INQ and higher FBS. among non-diabetic participants in the crude and adjusted model.
Table 5 shows how the INQ of each nutrient tertile is related to body composition factors. In the crude model, INQ of protein and choline is linked to lower visceral fat percentage in all populations and in both diabetic and non-diabetic groups. But this link did not remain significant after adjustment for confounders. INQ of riboflavin was linked to lower visceral fat percentage in all populations and in the diabetic group. In the crude model, however, this link was only shown in the adjusted model for the non-diabetic group. INQ of zinc was linked to lower visceral fat percentage in all populations and in the diabetic group. Furthermore, INQ of vitamin B6 was linked to lower visceral fat percentage in all populations and in both diabetic and
non-diabetic groups, in the crude and adjusted models. INQ of fiber, linoleic acid, linolenic acid, protein, riboflavin, choline, and zinc was linked to higher body fat percentage in all populations and in both diabetic and non-diabetic groups. The same link was found for INQ of carbohydrate and vitamin B6 in all populations and the diabetic group. These links, however, disappear after accounting for other factors. INQ of fiber, linoleic acid, linolenic acid, and zinc was linked to lower skeletal muscle percentage in all populations and in both diabetic and non-diabetic groups. The same link was found for the INQ of riboflavin and choline in all populations and for the INQ of protein and choline in the diabetic group. In the unadjusted model, INQ of fiber and linoleic acid was linked to higher BMI in all populations and the diabetic group. The same was true for the INQ of zinc in all populations. However, in the adjusted model, INQ of choline was linked to lower BMI in the diabetic group, and INQ of vitamin B6 was linked to lower BMI in the non-diabetic group.

Discussion
According to this study, a higher intake of the INQ of linoleic acid is linked to a lower odd of vascular occlusion based on GS and SS. Furthermore, an increase in fiber INQ is associated with decreased levels of TC and LDL-C. On the other hand, an increase in INQ of riboflavin and vitamin D is directly related to the rise in TC. The intake of protein has a direct relationship with the levels of HDL-C and FBS. Additionally, an increase in INQ of vitamin B6 is linked to an increase in TC, TG, and visceral fat percentage. Also, the INQ of vitamin B6 and choline has an inverse relationship with BMI.
Consistent with the results of this study, an umbrella review on 52 meta-analyses found that higher dietary fiber intake was associated with significant reductions in the TC and LDL (Fu et al., 2022). Additionally, data from another meta-analysis imply that every seven g/day increments in fiber consumption may reduce CVD risk by 9% (Threapleton et al., 2013). Dietary fiber is effective in reducing TC and LDL-C by increasing the rate of excretion of bile acids (Bartley et al., 2010, Pereira et al., 2004).
The results of a meta-analysis on 47 randomized controlled trials (RCTs) showed that alpha-linolenic acid (ALA) intake enhanced lipid profile by reducing TG, TC, LDL-C, and VLDL levels. (Yue et al., 2021). Moreover, meta-analysis studies conducted on cohort studies indicated that dietary ALA intake was associated with reduced risk of mortality from CVD (Naghshi et al., 2021, Yue et al., 2021). ALA benefits heart health due to its anti-inflammatory properties and ability to combat obesity and diabetes (Yuan et al., 2022).
Results of a large population study revealed that consumption of proteins in breakfast was positively related to HDL-C (Berryman et al., 2021). Furthermore, in the systematic review and meta-analysis of Santesso et al. (Santesso et al., 2012), the results indicated that HDL-C levels were higher in diets with higher protein content compared to those with lower protein content. Nevertheless, increasing dietary protein consumption while reducing carbohydrate intake is widely regarded as a beneficial approach for mitigating cardiometabolic risks. This notion is substantiated by numerous studies that have demonstrated improvements in blood lipid profiles among obese and overweight individuals (Clifton et al., 2009, Gardner et al., 2007, Layman et al., 2009). Proteins can exhibit varying effects on cholesterol metabolism depending on the type and composition of their amino acids. The exact processes by which plant proteins lower plasma cholesterol levels are unclear. However, there is evidence that plant proteins may reduce dietary cholesterol absorption and increase neutral and acidic sterols in feces. Additionally, there is growing evidence that animal proteins are digested faster than plant proteins. The higher proportion of phosphorylated amino acids in animal proteins can potentially interact with calcium and affect bile acid reabsorption (Forsythe et al., 1986). The results showed a positive linkage between riboflavin intake and TC. However, the results of other studies did not exactly confirm the statements made in this study. A cross-sectional study of 668 postmenopausal women showed a negative relationship between riboflavin intake and non-alcoholic fatty liver disease (Li et al., 2023). Riboflavin may help reduce lipid peroxidation (Ashoori and Saedisomeolia, 2014). Many animal studies have suggested that riboflavin deficiency has negative effects on lipid peroxidation (Huang et al., 2010, Wang et al., 2011). Findings from a large cross-sectional study in Korea suggested that low riboflavin intake was significantly associated with increased HDL-C levels in men (Shin and Kim, 2019).
Studies that assessed the effects of dietary choline and betaine on body composition (Gao et al., 2016, Konstantinova et al., 2008) have inconsistent results. A cross-sectional survey of 3214 Canadian subjects showed that dietary choline was associated with better body composition (Gao et al., 2016). On the other hand, the results of a large population-based study in Norway showed a positive relation between choline and BMI, percent body fat, and waist circumference (Konstantinova et al., 2008). The relationship between choline and body composition is complex and not entirely understood (Zhong et al., 2020). However, a study has suggested that a diet rich in both choline and betaine can lower the likelihood of hepatic steatosis linked to visceral obesity, with the extent of risk reduction correlating with the intake levels (Chang et al., 2022). In addition, the results of an animal study showed that choline and betaine supplementation may provide therapeutic benefits for the management of obesity and type 2 diabetes, as they have significant metabolic effects on fat breakdown, the tricarboxylic acid cycle, and mitochondrial oxidative phosphorylation processes (Sivanesan et al., 2018). In accordance with the results, a randomized controlled trial performed on 44 obese and overweight women reported the beneficial effect of vitamin B6 supplementation in reducing BMI and improving body composition (Haidari et al., 2021). Pyridoxine may be beneficial in regulating adipocytokine levels and ameliorating obesity by enhancing fat oxidation in skeletal muscle (Hagiwara et al., 2009).
The researchers found a direct relationship between vitamin B6 and TC, TG, and visceral fat percentage. On the other hand, the results of a 12-week trial on hyperglycemic patients showed that vitamin B6 supplementation can reduce TC (Hlais et al., 2012). The precise mechanism by which vitamin B6 affects the lipid profile is unclear. Vitamin B6 has been found to be connected with several processes, including the desaturation and elongation of fatty acids, methylation of phospholipids, and the transfer of unsaturated fatty acids from triglycerides to phospholipids. It has been reported that increased delta desaturase activity can lead to increased synthesis of prostaglandin E1, which may suppress cholesterol production and thus affect cholesterol concentration (Harripersad and Burger, 1997, Pregnolato et al., 1994).
A meta-analysis of 13 studies conducted by Huang et al. has shown that individuals with a vitamin D deficiency have higher levels of TC compared with those with normal levels (Huang et al., 2023). However, it has been observed in this study and other studies that the Iranian population, particularly women, has low levels of vitamin D (Emdadi et al., 2016, Jasemi et al., 2023). This factor may have influenced the results of this study. Studies have shown that vitamin D deficiency can be associated with a higher risk of cardiovascular diseases, increased inflammation, and oxidative stress (Surdu et al., 2021). Also, studies have shown that vitamin D deficiency has a negative effect on lipid profile levels, and an inverse relationship between vitamin D levels and TC, LDL-C, and TG has been pointed out in studies (Dziedzic et al., 2016, Lupton et al., 2016). Another study revealed that vitamin D deficiency increases serum cholesterol concentration by reducing vitamin D receptor activity and thereby increasing hepatic cholesterol biosynthesis (Li et al., 2016).
This study had a decent sample size, used a validated FFQ, and extracted macronutrients and micronutrients. However, some limitations could affect the results. Cross-sectional studies, which examine exposure and outcome simultaneously, cannot establish causality. Additionally, such studies can be subject to temporal and survival/selective biases. The INQ is based on the RDA but does not define the recommended intake for all nutrients. In this study, dietary information was collected using an FFQ, which may not be entirely accurate. The authors controlled for multiple potential confounding variables in the analysis, but residual confounding may still exist.
Conclusion
This study found that consuming more linolenic acid is linked to a lower chance of developing coronary artery occlusion based on GS and SS. The study also discovered that TC is positively associated with riboflavin, vitamin B6, and vitamin D INQ but negatively associated with fiber INQ. Additionally, LDL-C is inversely related to fiber intake. Fiber INQ was also inversely associated with LDL-C levels, while vitamin B6 and choline INQ were inversely associated with BMI. The study also found that higher levels of vitamin B6 are directly related to TC, TG, and visceral fat percentage. Prospective studies are needed to confirm or reject these findings.
Acknowledgements
 The authors would like to thank the participants, without whom this study would not have been possible.
Authors’ contribution
Najafi A, Sasanfar B, and Salehi-Abargouei A participated in the study design and analysis and drafted the initial version. Sasanfar B, Toorang F, and Salehi-Abargouei A helped with data analysis. Taftian M, Ahmadi Vasmehjani A, and Motallaei M contributed to data collection. Salehi-Abargouei A supervised the study, and all the authors reviewed the final version of the manuscript.
Table 1. Participants’ overall characteristics across category of Gensini and Syntax score.
Variables Gensini Score P-valuec Syntax Score P-valuec
Without coronary
stenosis (n=406)
With coronary stenosis
(n=206)
Without coronary stenosis
(n=407)
With coronary stenosis
(n=205)
Age (y) 55.88 ± 9.72a 58.02 ± 9.30 0.01 55.66 ± 9.74 58.47 ± 9.12 0.001
Body mass index (kg/m2) 27.84 ± 4.56 27.10 ± 3.92 0.04 27.91 ± 4.52 26.98 ± 3.99 0.01
Physical activity (MET-h/week) 67.26 ± 116.94 64.28 ± 120.29 0.76 69.80 ± 121.39 59.17 ± 110.81 0.29
Gender <0.001 <0.001
Male 200 (49.4)b 165 (80.1) 206 (50.7) 159 (77.6)
Female 205 (50.6) 41 (19.9) 200 (49.3) 46 (22.4)
Job <0.001 <0.001
Employee 19 (4.7) 11 (5.4) 18 (4.4) 12 (5.9)
Worker 36 (8.9) 18 (8.8) 38 (9.4) 16 (7.8)
Retired 42 (10.4) 45 (22.0) 44 (10.8) 43 (21.1)
Freelance 111 (27.4) 89 (43.4) 114 (28.1) 86 (42.2)
Housewife/unemployed 197 (48.6) 42 (20.5) 192 (47.3) 47 (23.0)
Education 0.24 0.41
Uneducated 102 (25.2) 40 (19.6) 100 (24.7) 42 (20.7)
No university degree 276 (68.3) 147 (72.1) 279 (68.9) 144 (70.9)
University degree 26 (6.4) 17 (8.3) 26 (6.4) 17 (8.4)
Married 0.08 0.45
Unmarried 1 (0.2.0) 4 (1.9) 2 (0.5) 3 (1.5)
Married 371 (92.3) 189 (91.7) 373 (92.6) 187 (91.2)
divorced/widowed 30 (7.5) 13 (6.3) 28 (6.9) 15 (7.3)
Economic status 0.02 0.14
Low 150 (37) 55 (26.8) 147 (36.2) 58 (28.4)
Middle 114 (28.1) 75 (36.6) 119 (29.3) 70 (34.3)
High 141 (34.8) 75 (36.6) 140 (34.5) 76 (37.3)
Menstrual <0.001 <0.001
Yes 59 (14.5) 6 (2.9) 139 (34.2) 41 (20.0)
No 145 (35.7) 35 (17.0) 60 (14.7) 5 (2.4.0)
Male 202 (49.8) 165 (80.1) 208 (51.1) 159 (77.6)
Smoking <0.001 <0.001
No 303 (74.6) 111 (53.9) 297 (73.0) 117 (57.1)
Former 12 (3.0) 8 (3.9) 14 (3.4) 6 (2.9)
Current 91 (22.4) 87 (42.2) 96 (23.6) 82 (40.0)
Drug addiction 0.006 0.01
No 337 (83.6) 151 (74.4) 335 (82.9) 153 (75.7)
Former 10 (2.5) 3 (1.5) 11 (2.7) 2 (1.0)
Current 56 (13.9) 49 (24.1) 58 (14.4) 47 (23.3)
Alcohol consumption 0.70 0.17
No 384 (95.0) 195 (96.1) 381 (94.3) 198 (97.5)
Yes 5 (1.2) 3 (1.5) 6 (1.5) 2 (1.0)
Stopped drinking 15 (3.7) 5 (2.5) 17 (4.2) 3 (1.5)
Diabetes 0.18 0.13
Yes 270 (66.7) 125 (61.3) 271 (66.9) 124 (60.8)
No 135 (33.3) 79 (38.7) 134 (33.1) 80 (39.2)
a: Values are mean±SD; b: n (%); c: χ2 Test for ordinal qualitative variables and t-test for continuous variables.
Table 2. Comparison of Index of Nutritional Quality (INQ) of the participants across category of Gensini and Syntax score.
Gensini Score P-valueb Syntax Score P-valueb
Without coronary stenosis
(n=406)
With coronary stenosis
(n=206)
without coronary stenosis
(n=406)
With coronary stenosis
(n=206)
Carbohydrate 3.09 ± 0.44a 3.12 ± 0.46 0.51 3.10 ± 0.45 3.11 ± 0.45 0.68
Fiber 1.52 ± 0.56 1.39 ± 0.54 0.007 1.50 ± 0.57 1.42 ± 0.52 0.08
Linoleic acid 0.0005 ± 0.0004 0.0004 ± 0.0003 0.02 0.0005 ± 0.0004 0.0004 ± 0.0003 0.001
Linolenic acid 0.13 ± 0.16 0.90 ± 0.90 0.006 0.13 ± 0.16 0.09 ± 0.09 <0.001
Protein 1.92 ± 0.48 1.85 ± 0.48 0.07 1.92 ± 0.49 1.84 ± 0.44 0.05
Thiamine 1.52 ± 0.37 1.51 ± 0.38 0.84 1.52 ± 0.38 1.51 ± 0.35 0.64
Riboflavin 14.04 ± 3.49 13.61 ± 3.56 0.15 14.05 ± 3.57 13.58 ± 3.4 0.12
Niacin 2.51 ± 0.98 2.50 ± 1.12 0.94 2.50 ± 0.96 2.52 ± 1.15 0.84
Pantothenic acid 1.36 ± 0.29 1.36 ± 0.29 0.77 1.36 ± 0.29 1.36 ± 0.29 0.81
Vitamin B6 1.8 ± 0.48 1.76 ± 0.55 0.38 1.81 ± 0.49 1.74 ± 0.52 0.09
Folate 1.13 ± 0.3 1.17 ± 0.41 0.14 1.13 ± 0.36 1.16 ± 0.32 0.43
Vitamin B12 1.85 ± 2.18 1.81 ± 1.49 0.82 1.89 ± 2.30 1.75 ± 1.07 0.41
Choline 0.75 ± 0.32 0.71 ± 0.22 0.90 0.75 ± 0.32 0.72 ± 0.22 0.30
Vitamin C 3.07 ± 1.54 3.00 ± 1.69 0.61 3.05 ± 1.54 3.05 ± 1.70 0.99
Vitamin A 1.00 ± 0.45 1.02 ± 0.71 0.62 1.01 ± 0.58 1.00 ± 0.48 0.84
Vitamin D 0.18 ± 0.14 0.17 ± 0.19 0.57 0.18 ± 0.14 0.18 ± 0.19 0.92
Vitamin E 0.86 ± 0.35 0.84 ± 0.35 0.48 0.85 ± 0.35 0.86 ± 0.36 0.79
Vitamin K 2.31 ± 1.85 2.28 ± 3.07 0.86 2.39 ± 2.76 2.11 ± 1.11 0.16
Sodium 6.82 ± 3.25 6.59 ± 3.71 0.45 6.85 ± 3.35 6.53 ± 3.53 0.27
Potassium 1.01 ± 0.23 1.04 ± 0.28 0.15 1.01 ± 0.25 1.04 ± 0.26 0.25
Calcium 0.74 ± 0.22 0.78 ± 0.28 0.07 0.74 ± 0.23 0.78 ± 0.26 0.11
Phosphorus 2.16 ± 0.42 2.15 ± 0.39 0.87 2.16 ± 0.42 2.15 ± 0.38 0.88
Magnesium 1.18 ± 0.27 1.10 ± 0.27 0.002 1.18 ± 0.29 1.10 ± 0.23 0.002
Iron 1.77 ± 0.52 1.93 ± 0.47 <0.001 1.77 ± 0.56 1.93 ± 0.35 <0.001
Zinc 1.53 ± 0.39 1.41 ± 0.40 0.001 1.53 ± 0.41 1.41 ± 0.37 0.001
Selenium 1.83 ± 0.46 1.81 ± 0.65 0.63 1.83 ± 0.47 1.82 ± 0.63 0.94
Copper 0.002 ± 0.0005 0.002 ± 0.0005 0.39 0.002 ± 0.0005 0.002 ± 0.0005 0.30
Manganese 3.43 ± 1.34 3.27 ± 0.99 0.15 3.45 ± 1.37 3.23 ± 0.91 0.04
Fluoride 0.81 ± 0.62 0.81 ± 0.63 0.99 0.82 ± 0.63 0.80 ± 0.61 0.65
a: Data are presented as mean ± SD; b: Obtained from the t-test.
Table 3. Association between tertiles of Index of Nutritional Quality (INQ) with coronary artery disease based on Gensini and Syntax score.
Variables Coronary stenosis based on Gensini Score P-valueb Coronary stenosis based on SYNTAX Score P-valueb
T1 T2 T3 T1 T2 T3
Carbohydrate
Crude Ref 0.92 (0.61-1.40)a 1.07 (0.70-1.61) 0.75 Ref 0.88 (0.58-1.34) 1.09 (0.72-1.65) 0.67
Model 1 Ref 1.03 (0.65-1.63) 1.06 (0.68-1.64) 0.78 Ref 0.95 (0.60-1.49) 1.06 (0.68-1.64) 0.78
Model 2 Ref 0.97 (0.57-1.65) 0.99 (0.60-1.65) 0.92 Ref 0.97 (0.58-1.63) 1.06 (0.64-1.73) 0.98
Fiber
Crude Ref 0.76 (0.50-1.14) 0.54 (0.35-0.82) 0.004 Ref 0.94 (0.62-1.41) 0.62 (0.41-0.95) 0.03
Model 1 Ref 0.93 (0.59-1.14) 1.35 (0.75-2.42) 0.39 Ref 1.10 (0.69-1.74) 1.27 (0.71-2.26) 0.42
Model 2 Ref 1.12 (0.66-1.89) 1.31 (0.66-2.61) 0.64 Ref 1.26 (0.75-2.13) 1.33 (0.68-2.60) 0.43
Linoleic acid
Crude Ref 0.96 (0.64-1.44) 0.51 (0.33-0.78) 0.002 Ref 0.98 (0.65-1.47) 0.48 (0.31-0.74) 0.001
Model 1 Ref 1.12 (0.69-1.81) 0.91 (0.55-1.50) 0.71 Ref 1.06 (0.66-1.71) 0.76 (0.46-1.26) 0.28
Model 2 Ref 1.08 (0.61-1.88) 0.88 (0.50-1.56) 0.80 Ref 1.01 (0.58-1.74) 0.69 (0.40-1.21) 0.39
Linolenic acid
Crude Ref 0.75 (0.50-1.12) 0.39 (0.25-0.60) <0.001 Ref 0.72 (0.48-1.07) 0.40 (0.26-0.61) <0.001
Model 1 Ref 0.86 (0.54-1.37) 0.67 (0.40-1.11) 0.12 Ref 0.79 (0.49-1.25) 0.62 (0.38-1.03) 0.06
Model 2 Ref 0.68 (0.40-1.16) 0.53 (0.29-0.94) 0.79 Ref 0.68 (0.40-1.14) 0.50 (0.28-0.88) 0.03
Protein
Crude Ref 0.61 (0.40-0.92) 0.57 (0.37-0.87) 0.008 Ref 0.62 (0.41-0.94) 0.58 (0.38-0.88) 0.01
Model 1 Ref 0.79 (0.50-1.24) 1.02 (0.63-1.63) 0.97 Ref 0.77 (0.49-1.22) 0.95 (0.59-1.52) 0.80
Model 2 Ref 0.75 (0.44-1.26) 0.87 (0.51-1.48) 0.64 Ref 0.79 (0.47-1.31) 0.78 (0.46-1.31) 0.33
Riboflavin
Crude Ref 0.78 (0.52-1.17) 0.60 (0.39-0.91) 0.01 Ref 0.83 (0.55-1.25) 0.62 (0.41-0.95) 0.03
Model 1 Ref 0.92 (0.59-1.44) 1.00 (0.62-1.59) 0.98 Ref 0.94 (0.60-1.48) 0.95 (0.59-1.51) 0.83
Model 2 Ref 0.85 (0.51-1.43) 0.9 (0.53-1.54) 0.88 Ref 0.87 (0.53-1.44) 1.01 (0.60-1.69) 0.93
Vitamin B6
Crude Ref 1.02 (0.68-1.54) 0.73 (0.48-1.22) 0.15 Ref 0.92 (0.61-1.38) 0.56 (0.37-0.87) 0.01
Model 1 Ref 1.5 (0.96-2.36) 1.19 (0.75-1.89) 0.41 Ref 1.26 (0.81-1.97) 0.86 (0.54-1.37) 0.58
Model 2 Ref 1.45 (0.88-2.37) 1.03 (0.61-1.71) 0.79 Ref 1.1 (0.67-1.78) 0.82 (0.49-1.36) 0.52
Choline
Crude Ref 0.8 (0.53-1.21) 0.57 (0.37-0.87) 0.01 Ref 0.96 (0.64-1.44) 0.65 (0.43-1.00) 0.05
Model 1 Ref 0.98 (0.62-1.54) 1.04 (0.64-1.69) 0.86 Ref 1.14 (0.73-1.79) 1.11 (0.68-1.81) 0.64
Model 2 Ref 0.91 (0.55-1.50) 1.1 (0.64-1.89) 0.72 Ref 1.15 (0.70-1.89) 1.31 (0.76-2.26) 0.31
Vitamin D
Crude Ref 1.14 (0.76-1.72) 0.65 (0.42-1.004) 0.05 Ref 1.12 (0.75-1.69) 0.81 (0.53-1.23) 0.34
Model 1 Ref 1.13 (0.72-1.79) 0.62 (0.39-0.98) 0.03 Ref 1.12 (0.71-1.76) 0.81 (0.51-1.27) 0.34
Model 2 Ref 1.02 (0.62-1.67) 0.7 (0.42-1.15) 0.14 Ref 1.04 (0.63-1.71) 0.91 (0.55-1.48) 0.64
Zinc
Crude Ref 0.82 (0.55-1.23) 0.4 (0.26-0.62) <0.001 Ref 0.75 (0.50-1.13) 0.4 (0.26-0.62) <0.001
Model 1 Ref 1.16 (0.76-1.79) 1.09 (0.61-1.92) 0.67 Ref 0.99 (0.64-1.53) 0.87 (0.49-1.52) 0.67
Model 2 Ref 1.11 (0.69-1.79) 0.92 (0.48-1.74) 0.96 Ref 0.91 (0.57-1.47) 0.69 (0.37-1.30) 0.35
a: Data are presented as OR and 95% CI; b: Obtained from the binary logistic regression; Model 1: adjusted for age, energy, and sex; Model 2: Model 1 + adjusted for married, menopausal status, physical activity, economic status, job, educational level, smoking, drug addiction, Diabetes, and body mass index..
Table 4. Association between tertiles of Index of Nutritional Quality (INQ) and lipid profile and fasting blood sugar.
Variables TC TG LDL-C HDL-C FBS
Crude Adjustede Crude Adjusted Crude Adjusted Crude Adjusted Crude Adjusted
All population
Carbohydrate
   T1 209.10 ± 8.94d 211.77 ± 9.84 150.63 ± 7.16 155.80 ± 7.18 97.98 ± 3.55 95.91 ± 3.84 49.10 ± 1.07 49.13 ± 1.15 135.78 ± 4.61 139.6 ± 4.5
   T2 193.43 ± 8.78 193.54 ± 9.46 147.33 ± 7.14 141.61 ± 7.02 98.54 ± 3.54 98.56 ± 3.76 47.33 ± 1.07 47.04 ± 1.13 131.31 ± 4.62 127.05 ± 4.45
   T3 188.73 ± 8.81 189.24 ± 9.47 167.54 ± 7.11 165.77 ± 6.97 95.31 ± 3.54 95.92 ± 3.75 49.73 ± 1.05 49.50 ± 1.11 134.98 ± 4.67 131.52 ± 4.48
   P-valuec 0.24 0.22 0.1 0.05 0.78 0.85 0.25 0.26 0.76 0.13
Fiber
   T1 220.84 ± 8.64 a 219.96 ± 10.83 a 153.67 ± 7.04 153.19 ± 8.02 105.30 ± 3.42 a 106.18 ± 4.16 a 47.54 ± 1.05 47.84 ± 1.27 131.23 ± 4.60 134.66 ± 5.23
   T2 183.32 ± 8.53 b 184.13 ± 9.34 b 148.83 ± 6.94 149.10 ± 6.92 93.08 ± 3.42 b 90.95 ± 3.65 b 49.10 ± 1.04 48.99 ± 1.11 132.66 ± 4.60 131.14 ± 4.5
   T3 186.12 ± 9.20 b 188.65 ± 11.76 165.01 ± 7.57 161.41 ± 8.82 92.90 ± 3.73 b 92.65 ± 4.63 49.72 ± 1.12 48.83 ± 1.39 138.56 ± 4.69 132.13 ± 5.42
    P-value 0.003 0.04 0.27 0.55 0.01 0.02 0.33 0.79 0.50 0.87
Linoleic acid
   T1 197.43 ± 9.25 189.63 ± 11.2 149.67 ± 7.46 142.77 ± 8.25 95.82 ± 3.67 94.00 ± 4.37 47.44 ± 1.11 47.68 ± 1.31 136.81 ± 4.72 134.21 ± 5.11
   T2 200.08 ± 8.73 200.60 ± 9.69 161.37 ± 7.02 161.72 ± 7.12 100.65 ± 3.47 99.47 ± 3.82 49.77 ± 1.05 49.56 ± 1.15 135.51 ± 4.62 131.59 ± 4.63
   T3 193.60 ± 8.73 202.17 ± 9.55 154.31 ± 7.07 156.86 ± 7.06 95.34 ± 3.50 96.72 ± 3.77 48.90 ± 1.05 48.33 ± 1.12 130.17 ± 4.57 132.21 ± 4.53
   P-value 0.87 0.70 0.51 0.25 0.49 0.66 0.31 0.55 0.56 0.93
Linolenic acid
   T1 199.97 ± 9.03 201.82 ± 10.91 156.20 ± 7.31 150.14 ± 8.07 96.81 ± 3.62 98.37 ± 4.31 48.39 ± 1.09 49.26 ± 1.29 141.47 ± 4.71 137.59 ± 5.03
   T2 203.28 ± 8.68 203.51 ± 9.48 155.92 ± 7.06 157.62 ± 7.03 99.66 ± 3.48 99.30 ± 3.75 48.64 ± 1.05 48.54 ± 1.12 129.77 ± 4.54 127.57 ± 4.39
   T3 187.53 ± 8.93 187.87 ± 10.04 153.89 ± 7.21 154.63 ± 7.39 95.39 ± 3.55 92.70 ± 3.93 49.2 ± 1.07 47.88 ± 1.17 131.47 ± 4.63 133.37 ± 4.71
   P-value 0.41 0.48 0.97 0.80 0.68 0.44 0.86 0.75 0.16 0.32
Protein
   T1 199.65 ± 9.01 198.86 ± 10.26 151.43 ± 7.28 154.61 ± 7.57 98.37 ± 3.58 99.81 ± 3.99 47.96 ± 1.07 48.77 ± 1.18 129.48 ± 4.65 126.68 ± 4.74
   T2 193.20 ± 8.67 196.16 ± 9.40 157.47 ± 7.03 153.56 ± 6.97 94.22 ± 3.46 93.35 ± 3.7 46.87 ± 1.03 a 46.22 ± 1.10 a 132.22 ± 4.60 132.58 ± 4.46
   T3 198.52 ± 9.01 198.63 ± 9.77 156.94 ± 7.25 154.69 ± 7.19 99.63 ± 3.60 97.53 ± 3.83 51.55 ± 1.07 b 50.77 ± 1.13 b 140.59 ± 4.63 138.52 ± 4.53
   P-value 0.85 0.97 0.80 0.99 0.52 0.49 0.005 0.01 0.21 0.22
Riboflavin
   T1 195.29 ± 8.61 184.60 ± 9.44 a 154.84 ± 6.97 151.67 ± 7.03 100.24 ± 3.38 98.34 ± 3.66 48.47 ± 1.02 48.72 ± 1.10 137.17 ± 4.64 134.99 ± 4.62
   T2 186.36 ± 8.81 190.60 ± 9.37 148.97 ± 7.12 153.33 ± 6.97 95.71 ± 3.56 94.13 ± 3.76 48.07 ± 1.07 47.56 ± 1.12 127.18 ± 4.56 128.89 ± 4.42
   T3 210.55 ± 9.17 221.38 ± 10.21b 162.91 ± 7.46 158.4 ± 7.63 95.56 ± 3.72 97.93 ± 4.08 49.82 ± 1.12 49.43 ± 1.22 138.24 ± 4.67 134.14 ± 4.69
   P-value 0.16 0.02 0.40 0.81 0.55 0.68 0.50 0.51 0.17 0.58
Vitamin B6
   T1 188.26 ± 8.44 185.59 ± 9.16 a 141.12 ± 6.74 a 144.00 ± 6.74 a 95.91 ± 3.34 95.82 ± 3.56 47.78 ± 1.01 47.99 ± 1.07 133.49 ± 4.57 134.28 ± 4.46
   T2 189.32 ± 8.70 189.58 ± 9.55 149.18 ± 6.92 a 147.21 ± 7.01 a 96.01 ± 3.51 94.05 ± 3.80 49.16 ± 1.06 48.42 ± 1.14 133.73 ± 4.67 131.6 ± 4.59
   T3 217.05 ± 9.44 222.75 ± 10.26 b 180.61 ± 7.57 b 175.5 ± 7.58 b 100.80 ± 3.85 101.39 ± 4.14 49.52 ± 1.15 49.41 ± 1.22 135.10 ± 4.67 131.92 ± 4.61
   P-value 0.04 0.01 <0.001 0.005 0.56 0.41 0.46 0.69 0.96 0.90
Choline
   T1 192.23 ± 8.63 182.20 ± 9.83 152.10 ± 6.98 151.30 ± 7.30 93.75 ± 3.42 91.54 ± 3.83 47.42 ± 1.03 47.31 ± 1.15 133.80 ± 4.62 134.02 ± 4.81
   T2 192.83 ± 8.90 197.68 ± 9.67 157.38 ± 7.18 158.6 ± 7.16 98.73 ± 3.54 98.56 ± 3.81 48.54 ± 1.06 48.44 ± 1.14 127.24 ± 4.62 126.92 ± 4.47
   T3 206.81 ± 9.13 215.57 ± 10.25 156.82 ± 7.42 153.12 ± 7.61 99.95 ± 3.69 101.19 ± 4.08 50.46 ± 1.10 50.06 ± 1.21 141.29 ± 4.63 136.92 ± 4.65
   P-value 0.43 0.08 0.84 0.76 0.41 0.23 0.13 0.29 0.10 0.27
Vitamin D
   T1 191.88 ± 8.81 192.53 ± 9.60 153.16 ± 7.17 151.71 ± 7.17 94.91 ± 3.56 94.41 ± 3.81 47.96 ± 1.07 47.09 ± 1.13 133.59 ± 4.63 131.56 ± 4.56
   T2 186.23 ± 8.46 184.06 ± 8.95 a 152.76 ± 6.93 153.31 ± 6.72 97.11 ± 3.40 95.10 ± 3.55 49.11 ± 1.03 48.92 ± 1.06 128.63 ± 4.58 129.57 ± 4.43
   T3 215.14 ± 9.21 221.61 ± 10.05 b 160.23 ± 7.44 158.34 ± 7.44 99.98 ± 3.67 101.70 ± 3.96 49.12 ± 1.11 49.73 ± 1.19 139.99 ± 4.64 136.99 ± 4.49
   P-value 0.05 0.01 0.71 0.80 0.61 0.34 0.67 0.26 0.22 0.47
Zinc
   T1 195.32 ± 9.07 192.52 ± 10.78 154.26 ± 7.32 154.72 ± 7.94 97.75 ± 3.61 98.55 ± 4.17 47.76 ± 1.08 48.68 ± 1.25 128.68 ± 4.61 126.87 ± 5.01
   T2 200.8 ± 8.88 200.90 ± 9.48 149.27 ± 7.17 152.53 ± 7.00 98.00 ± 3.53 97.42 ± 3.69 47.93 ± 1.06 48.12 ± 1.10 137.64 ± 4.69 138.44 ± 4.49
   T3 194.95 ± 8.73 199.84 ± 10.97 162.20 ± 7.04 155.53 ± 8.05 96.26 ± 3.52 94.56 ± 4.29 50.48 ± 1.05 48.80 ± 1.28 136.06 ± 4.59 132.81 ± 5.29
   P-value 0.87 0.82 0.43 0.95 0.93 0.82 0.13 0.89 0.34 0.20
With diabetes
Carbohydrate
   T1 231.05 ± 18.79 207.33 ± 20.93 190.25 ± 14.49 175.69 ± 15.92 94.88 ± 6.39 84.38 ± 7.03 50.18 ± 2.04 49.52 ± 2.20 185.46 ± 12.15 188.11 ± 13.19
   T2 208.65 ± 14.07 222.99 ± 15.31 172.93 ± 10.85 173.94 ± 11.65 99.91 ± 4.82 101.14 ± 5.22 47.41 ± 1.54 46.61 ± 1.63 158.52 ± 9.39 153.15 ± 10.15
   T3 194.06 ± 14.75 195.53 ± 16.10 194.44 ± 11.38 203.32 ± 12.25 91.35 ± 5.06 91.77 ± 5.50 48.50 ± 1.62 48.39 ± 1.72 164.91 ± 10.02 164.88 ± 10.87
   P-value 0.30 0.48 0.36 0.18 0.47 0.17 0.55 0.57 0.20 0.12
Fiber
   T1 258.91 ± 18.34 a 242.15 ± 23.06 199.24 ± 14.50 201.02 ± 17.75 99.68 ± 6.40 100.02 ± 7.85 46.48 ± 2.04 46.49 ± 2.42 166.25 ± 12.92 149.18 ± 15.69
   T2 202.92 ± 14.90 202.93 ± 16.66 187.67 ± 11.78 186.71 ± 12.83 97.19 ± 5.25 94.85 ± 5.73 49.45 ± 1.67 49.67 ± 1.77 167.83 ± 10.03 160.07 ± 10.87
   T3 186.00 ± 13.30 b 196.86 ± 17.46 174.83 ± 10.54 174.19 ± 13.45 92.18 ± 4.69 89.88 ± 6.00 48.70 ± 1.49 47.26 ± 1.85 167.32 ± 9.24 175.48 ± 11.71
   P-value 0.006 0.30 0.38 0.56 0.59 0.66 0.52 0.44 0.99 0.49
Linoleic acid
   T1 222.69 ± 16.17 195.93 ± 21.88 173.01 ± 12.48 170.85 ± 17.00 93.36 ± 5.52 89.52 ± 7.50 44.63 ± 1.72 a 44.72 ± 2.28 167.89 ± 10.71 165.83 ± 14.71
   T2 191.07 ± 14.89 191.16 ± 16.83 194.58 ± 11.49 191.29 ± 13.00 97.87 ± 5.12 97.90 ± 5.86 51.09 ± 1.60 b 51.27 ± 1.78 170.45 ± 10.09 166.1 ± 11.28
   T3 214.00 ± 15.56 241.54 ± 18.43 184.98 ± 12.01 191.03 ± 14.32 95.28 ± 5.36 94.18 ± 6.41 49.15 ± 1.67 47.39 ± 1.95 163.32 ± 10.46 164.64 ± 12.4
   P-value 0.32 0.10 0.44 0.65 0.83 0.70 0.02 0.07 0.88 0.99
Linolenic acid
   T1 224.88 ± 15.13 221.78 ± 20.05 191.05 ± 11.70 198.86 ± 15.30 96.97 ± 5.17 97.24 ± 6.75 48.33 ± 1.65 50.28 ± 2.07 175.90 ± 10.19 180.12 ± 12.84
   T2 208.23 ± 15.41 206.26 ± 17.81 189.01 ± 11.92 185.32 ± 13.59 96.64 ± 5.36 96.90 ± 6.12 48.96 ± 1.71 48.44 ± 1.88 155.36 ± 10.04 149.79 ± 10.86
   T3 190.04 ± 16.00 200.01 ± 18.87 173.21 ± 12.37 168.80 ± 14.39 93.05 ± 5.46 87.36 ± 6.39 48.04 ± 1.75 44.70 ± 1.96 171.49 ± 10.91 168.71 ± 12.47
   P-value 0.28 0.76 0.52 0.41 0.85 0.47 0.92 0.16 0.32 0.20
Protein
   T1 228.50 ± 16.34 220.28 ± 19.45 202.27 ± 12.57 209.50 ± 14.72 98.35 ± 5.57 101.77 ± 6.54 47.56 ± 1.78 48.16 ± 2.03 161.94 ± 11.15 159.95 ± 12.97
   T2 197.99 ± 15.02 206.06 ± 16.12 178.60 ± 11.55 178.56 ± 12.20 96.05 ± 5.16 93.19 ± 5.48 47.85 ± 1.65 46.29 ± 1.70 166.77 ± 10.31 164.7 ± 10.92
   T3 201.50 ± 15.28 204.53 ± 16.75 175.88 ± 11.75 170.73 ± 12.67 92.73 ± 5.26 88.22 ± 5.72 49.86 ± 1.68 49.39 ± 1.77 171.98 ± 9.89 170.48 ± 10.74
   P-value 0.33 0.82 0.25 0.15 0.76 0.33 0.58 0.44 0.79 0.83
Riboflavin
   T1 206.01 ± 16.25 190.03 ± 17.37 189.86 ± 12.54 191.57 ± 13.38 93.09 ± 5.52 92.00 ± 5.90 48.28 ± 1.76 48.65 ± 1.82 168.06 ± 10.86 160.09 ± 11.81
   T2 198.78 ± 16.76 218.20 ± 18.51 179.74 ± 12.93 183.34 ± 14.26 98.80 ± 5.75 99.34 ± 6.40 47.00 ± 1.83 45.80 ± 1.98 158.78 ± 11.04 163.05 ± 12.06
   T3 216.97 ± 14.14 219.76 ± 16.01 184.53 ± 10.91 180.43 ± 12.33 95.31 ± 4.84 91.74 ± 5.51 49.60 ± 1.54 48.84 ± 1.70 173.01 ± 9.50 171.78 ± 10.62
   P-value 0.69 0.40 0.85 0.82 0.77 0.63 0.55 0.47 0.61 0.75
Vitamin B6
   T1 205.91 ± 16.31 198.42 ± 17.81 180.26 ± 12.45 184.48 ± 13.62 96.52 ± 5.56 95.90 ± 6.03 46.09 ± 1.77 45.87 ± 1.87 167.34 ± 10.79 171.83 ± 11.9
   T2 193.26 ± 14.50 200.28 ± 16.18 169.05 ± 11.07 170.57 ± 12.37 91.51 ± 4.98 87.29 ± 5.53 49.51 ± 1.58 47.74 ± 1.71 164.74 ± 10.03 159.77 ± 11.07
   T3 228.68 ± 15.83 232.37 ± 17.98 207.79 ± 12.09 202.31 ± 13.75 99.66 ± 5.45 100.11 ± 6.19 49.44 ± 1.73 50.22 ± 1.91 170.03 ± 10.47 165.54 ± 11.83
   P-value 0.25 0.33 0.05 0.24 0.53 0.30 0.28 0.29 0.93 0.77
Choline
   T1 214.09 ± 16.97 195.95 ± 19.66 182.46 ± 13.06 187.98 ± 15.11 84.91 ± 5.67 84.96 ± 6.62 46.88 ± 1.82 47.38 ± 2.05 168.26 ± 11.12 171.85 ± 13.14
   T2 207.33 ± 15.81 205.55 ± 16.91 192.04 ± 12.17 188.15 ± 13.00 101.01 ± 5.33 97.93 ± 5.76 47.28 ± 1.71 45.92 ± 1.78 157.39 ± 10.76 158.29 ± 11.64
   T3 205.10 ± 14.39 223.79 ± 16.92 180.43 ± 11.07 179.56 ± 13.00 98.98 ± 4.84 97.67 ± 5.77 50.55 ± 1.56 50.04 ± 1.79 174.29 ± 9.49 168.38 ± 11.05
   P-value 0.91 0.58 0.76 0.88 0.08 0.29 0.22 0.28 0.49 0.63
Vitamin D
   T1 202.27 ± 15.98 197.21 ± 17.33 176.95 ± 12.39 174.36 ± 13.41 95.56 ± 5.52 94.23 ± 6.00 47.84 ± 1.78 46.49 ± 1.87 165.08 ± 10.30 165.75 ± 11.15
   T2 186.43 ± 14.71 191.21 ± 15.56 173.51 ± 11.41 176.95 ± 12.04 88.93 ± 5.03 86.40 ± 5.30 47.62 ± 1.62 46.91 ± 1.65 161.66 ± 10.86 160.17 ± 11.35
   T3 237.98 ± 15.38 243.45 ± 17.12 204.35 ± 11.92 204.36 ± 13.24 103.11 ± 5.3 102.90 ± 5.94 49.92 ± 1.71 50.47 ± 1.85 174.26 ± 10.08 170.7 ± 10.78
   P-value 0.05 0.06 0.13 0.21 0.15 0.12 0.57 0.26 0.67 0.82
Zinc
   T1 212.04 ± 17.35 188.85 ± 21.41 192.43 ± 13.36 195.47 ± 16.45 89.80 ± 5.86 88.43 ± 7.24 47.08 ± 1.87 48.05 ± 2.25 155.97 ± 11.68 149.51 ± 14.58
   T2 211.72 ± 16.61 213.13 ± 17.70 181.13 ± 12.79 185.63 ± 13.59 97.29 ± 5.61 97.68 ± 6.00 48.12 ± 1.79 46.84 ± 1.86 183.30 ± 10.88 179.97 ± 11.82
   T3 203.81 ± 13.66 220.41 ± 16.94 181.16 ± 10.51 177.56 ± 13.01 98.16 ± 4.68 94.97 ± 5.80 49.54 ± 1.50 48.59 ± 1.81 163.06 ± 9.01 165.01 ± 11.35
   P-value 0.90 0.55 0.79 0.74 0.50 0.60 0.57 0.79 0.19 0.22
Without diabetes
Carbohydrate
   T1 201.02 ± 9.83 209.36 ± 10.87 136.54 ± 7.66 138.78 ± 7.66 99.13 ± 4.33 101.14 ± 4.65 48.71 ± 1.27 49.17 ± 1.35 118.99 ± 3.18 117.66 ± 3.18
   T2 180.56 ± 11.24 175.43 ± 12.19 125.09 ± 8.97 122.55 ± 8.82 97.31 ± 5.08 95.88 ± 5.38 47.26 ± 1.49 47.49 ± 1.56 110.56 ± 3.65 112.65 ± 3.56
   T3 184.44 ± 10.97 183.07 ± 11.69 147.78 ± 8.63 143.05 ± 8.35 97.76 ± 4.91 98.19 ± 5.12 50.50 ± 1.47 49.97 ± 1.44 116.66 ± 3.57 113.46 ± 3.46
   P-value 0.33 0.09 0.19 0.22 0.95 0.76 0.28 0.51 0.21 0.52
Fiber
   T1 207.78 ± 9.44 a 214.31 ± 11.89 a 138.35 ± 7.45 131.34 ± 8.43 107.24 ± 4.10 a 109.88 ± 4.96 a 47.90 ± 1.23 48.54 ± 1.49 120.54 ± 3.13 120.39 ± 3.62
   T2 171.13 ± 10.22 b 170.41 ± 11.36 b 125.43 ± 8.06 125.39 ± 8.08 89.98 ± 4.52 b 89.04 ± 4.88 b 48.77 ± 1.34 49.16 ± 1.43 111.57 ± 3.49 112.89 ± 3.49
   T3 186.26 ± 12.83 179.12 ± 16.31 152.94 ± 10.35 157.32 ± 11.82 93.85 ± 8.58 92.38 ± 7.07 50.95 ± 1.69 49.32 ± 2.04 113.91 ± 3.82 109.14 ± 4.51
   P-value 0.03 0.03 0.10 0.08 0.01 0.01 0.34 0.95 0.13 0.19
Linoleic acid
   T1 181.84 ± 11.03 180.85 ± 13.16 135.26 ± 8.75 128.51 ± 9.39 97.41 ± 4.91 95.12 ± 5.67 49.22 ± 1.44 49.39 ± 1.64 119.85 ± 3.50 117.48 ± 3.7
   T2 205.96 ± 10.64 203.15 ± 12.09 138.97 ± 8.40 139.60 ± 8.59 102.11 ± 4.73 100.76 ± 5.26 48.74 ± 1.39 48.27 ± 1.53 114.87 ± 3.50 117.87 ± 3.62
   T3 181.76 ± 10.29 186.86 ± 11.28 136.31 ± 8.21 136.94 ± 8.10 95.37 ± 4.62 99.60 ± 4.90 48.75 ± 1.34 49.19 ± 1.40 112.98 ± 3.37 114.99 ± 3.35
   P-value 0.18 0.44 0.95 0.69 0.58 0.76 0.96 0.87 0.35 0.58
Linolenic acid
   T1 182.22 ± 11.13 186.60 ± 13.17 131.37 ± 8.79 125.03 ± 9.35 96.69 ± 5.02 97.8 0± 5.77 48.43 ± 1.46 48.81 ± 1.67 119.96 ± 3.59 115.42 ± 3.8
   T2 200.13 ± 10.38 201.06 ± 11.40 135.73 ± 8.24 135.61 ± 8.13 101.03 ± 4.60 102.13 ± 4.91 48.33 ± 1.35 48.98 ± 1.42 115.42 ± 3.41 114.19 ± 3.37
   T3 186.09 ± 10.56 182.66 ± 12.00 142.95 ± 8.29 143.97 ± 8.45 96.79 ± 4.68 95.60 ± 5.15 49.86 ± 1.36 49.02 ± 1.48 112.58 ± 3.37 114.87 ± 3.48
   P-value 0.45 0.51 0.62 0.35 0.75 0.65 0.67 0.99 0.32 0.97
Protein
   T1 183.78 ± 10.57 184.06 ± 12.07 123.48 ± 8.29 122.04 ± 8.52 98.39 ± 4.65 99.54 ± 5.13 48.19 ± 1.34 48.86 ± 1.46 114.34 ± 3.36 108.94 ± 3.41 a
   T2 189.81 ± 10.52 192.86 ± 11.65 143.53 ± 8.29 140.47 ± 8.27 92.46 ± 4.65 93.37 ± 5.02 46.08 ± 1.34 a 46.36 ± 1.43 a 113.18 ± 3.45 114.21 ± 3.39
   T3 196.50 ± 11.02 195.01 ± 12.18 144.16 ± 8.58 144.16 ± 8.54 104.56 ± 4.89 103.29 ± 5.21 52.71 ± 1.40 b 51.77 ± 1.48 b 120.30 ± 3.56 121.99 ± 3.53 b
   P-value 0.70 0.81 0.13 0.17 0.20 0.38 0.003 0.03 0.30 0.03
Riboflavin
   T1 189.94 ± 9.94 181.85 ± 11.21 137.34 ± 7.87 129.11 ± 8.05 103.82 ± 4.29 101.65 ± 4.72 48.56 ± 1.27 48.52 ± 1.38 112.20 ± 3.37 119.81 ± 3.43
   T2 179.85 ± 10.20 178.29 ± 10.76 a 133.65 ± 8.04 134.80 ± 7.70 93.60 ± 4.58 93.02 ± 4.76 48.48 ± 1.33 48.43 ± 1.36 112.97 ± 3.28 110.45 ± 3.22
   T3 204.12 ± 12.24 220.99 ± 13.78 b 140.96 ± 9.77 145.45 ± 9.90 95.84 ± 5.59 102.00 ± 6.12 50.06 ± 1.64 50.39 ± 1.75 111.77 ± 3.71 114.29 ± 3.79
   P-value 0.31 0.04 0.84 0.47 0.23 0.34 0.71 0.64 0.06 0.14
Vitamin B6
   T1 180.09 ± 9.63 178.69 ± 10.6 123.03 ± 7.50 a 122.36 ± 7.48 a 95.62 ± 4.21 95.82 ± 4.49 48.55 ± 1.23 48.68 ± 1.3 117.57 ± 3.32 113.57 ± 3.30
   T2 186.01 ± 10.89 187.03 ± 12.15 134.22 ± 8.43 135.02 ± 8.54 99.00 ± 4.91 100.83 ± 5.31 48.75 ± 1.45 49.60 ± 1.54 114.39 ± 3.58 116.13 ± 3.59
   T3 208.65 ± 11.64 211.33 ± 12.74 160.70 ± 9.17 b 154.66 ± 9.05 b 101.69 ± 5.35 100.71 ± 5.69 49.58 ± 1.54 48.66 ± 1.60 115.26 ± 3.51 114.94 ± 3.46
   P-value 0.15 0.15 0.007 0.02 0.66 0.72 0.86 0.88 0.79 0.87
Choline
   T1 182.56 ± 9.73 174.65 ± 11.29 138.67 ± 7.72 129.82 ± 8.08 97.81 ± 4.32 96.18 ± 4.83 47.67 ± 1.27 47.41 ± 1.40 118.02 ± 3.34 113.59 ± 3.51
   T2 183.68 ± 10.64 190.18 ± 11.86 136.31 ± 8.40 140.01 ± 8.47 96.83 ± 4.71 98.85 ± 5.15 49.17 ± 1.37 50.05 ± 1.48 112.53 ± 3.40 111.89 ± 3.35
   T3 208.36 ± 11.86 213.44 ± 13.19 134.91 ± 9.48 137.74 ± 9.52 100.92 ± 5.44 102.16 ± 5.83 50.38 ± 1.56 49.86 ± 1.65 117.00 ± 3.66 119.42 ± 3.66
   P-value 0.19 0.11 0.95 0.68 0.84 0.75 0.39 0.40 0.48 0.29
Vitamin D
   T1 185.87 ± 10.44 189.91 ± 11.68 139.86 ± 8.23 136.45 ± 8.34 94.00 ± 4.66 94.21 ± 5.05 47.89 ± 1.35 46.99 ± 1.44 115.87 ± 3.5 114.76 ± 3.51
   T2 186.11 ± 10.21 180.27 ± 11.03 139.60 ± 8.14 140.42 ± 7.94 102.53 ± 4.56 100.99 ± 4.79 50.08 ± 1.33 50.33 ± 1.38 112.70 ± 3.33 113.07 ± 3.31
   T3 198.91 ± 11.42 205.29 ± 12.71 129.68 ± 8.89 127.39 ± 8.94 97.74 ± 5.00 100.96 ± 5.44 48.55 ± 1.47 49.58 ± 1.57 119.08 ± 3.53 116.86 ± 3.49
   P-value 0.63 0.33 0.63 0.54 0.42 0.57 0.50 0.24 0.42 0.73
Zinc
   T1 187.33 ± 10.41 191.33 ± 12.3 136.00 ± 8.20 130.94 ± 8.68 101.72 ± 4.59 104.70 ± 5.18 48.10 ± 1.34 49.43 ± 1.51 117.88 ± 3.26 112.85 ± 3.56
   T2 194.96 ± 10.35 195.22 ± 11.24 131.53 ± 8.15 133.46 ± 7.98 97.91 ± 4.57 97.28 ± 4.78 47.70 ± 1.33 48.23 ± 1.38 115.70 ± 3.43 115.78 ± 3.34
   T3 186.67 ± 11.45 183.92 ± 14.65 144.49 ± 9.02 142.91 ± 10.24 94.39 ± 5.15 92.70 ± 6.21 51.36 ± 1.48 49.24 ± 1.78 113.26 ± 3.75 116.24 ± 4.38
   P-value 0.82 0.83 0.56 0.70 0.56 0.36 0.14 0.81 0.64 0.8
a, b: Values with different superscripts were significantly different. (P <0.05); C: ANCOVA was used. Bonferroni was used for multiple comparisons; d:  Data are presented as mean ± SE; e: Adjusted for age, energy, sex, married status, menopausal status, physical activity, economic status, job, educational level, smoking, drug addiction, diabetes, and body mass indec. TC: total cholesterol; TG: Triglyceride; LDL-C: Low density lipoprotein; HDL-C: High density lipoprotein; FBS: Fasting blood sugar.
Table 5. Association between tertiles of Index of Nutritional Quality (INQ)  and body composition factor.
Variables Waist circumference Visceral fat percentage Body fat percentage Skeletal muscle percentage Body mass index
Crude Adjustedf Crude Adjusted Crude Adjusted Crude Adjusted Crude Adjusted
All population
Carbohydrate
   T1 99.05 ± 0.89 99.84 ± 0.65 10.56 ± 0.29 10.69 ± 0.16 30.78 ± 0.79 a 32.11 ± 0.33 31.36 ± 0.75 30.58 ± 0.70 27.30 ± 0.31 27.49 ± 0.31
   T2 100.49 ± 0.88 100.04 ± 0.65 10.9 ± 0.28 11.00 ± 0.15 34.02 ± 0.79 b 32.68 ± 0.32 29.27 ± 0.74 30.08 ± 0.69 27.74 ± 0.3 27.45 ± 0.30
   T3 100.63 ± 0.89 100.14 ± 0.65 11.38 ± 0.29 10.96 ± 0.15 32.80 ± 0.80 32.62 ± 0.33 29.82 ± 0.75 29.99 ± 0.70 27.73 ± 0.31 27.75 ± 0.31
   P-valued 0.38 0.94 0.14 0.35 0.01 0.41 0.13 0.81 0.52 0.76
Fiber
   T1 99.63 ± 0.9 100.53 ± 0.76 11.11 ± 0.29 10.76 ± 0.15 26.85 ± 0.71 a 32.13 ± 0.38 32.98 ± 0.73 a 29.22 ± 0.81 26.86 ± 0.31 a 27.83 ± 0.36
   T2 99.76 ± 0.89 99.68 ± 0.65 11.05 ± 0.28 10.93 ± 0.15 31.81 ± 0.7 b 32.44 ± 0.33 31.39 ± 0.71 a 31.51 ± 0.70 27.44 ± 0.30 27.46 ± 0.31
   T3 100.82 ± 0.89 99.82 ± 0.77 10.67 ± 0.29 10.96 ± 0.18 39.06 ± 0.71 c 32.84 ± 0.39 25.99 ± 0.72 b 29.88 ± 0.83 28.47 ± 0.30b 27.4 ± 0.36
   P-value 0.58 0.69 0.51 0.73 < 0.001 0.52 < 0.001 0.06 0.001 0.69
Linoleic acid
   T1 99.1 ± 0.9 100.26 ± 0.72 11.16 ± 0.29 10.94 ± 0.17 28.24 ± 0.76 a 32.78 ± 0.36 33.28 ± 0.74 a 30.82 ± 0.78 26.83 ± 0.31 a 27.27 ± 0.34
   T2 100.56 ± 0.89 99.32 ± 0.67 11.30 ± 0.29 10.82 ± 0.16 33.16 ± 0.76 b 32.73 ± 0.34 29.20 ± 0.74 b 29.51 ± 0.73 27.84 ± 0.31 27.96 ± 0.32
   T3 100.52 ± 0.88 100.42 ± 0.66 10.39 ± 0.28 10.89 ± 0.16 36.26 ± 0.75 c 31.93 ± 0.33 27.96 ± 0.72 b 30.30 ± 0.71 28.08 ± 0.30 b 27.46 ± 0.31
   P-value 0.42 0.45 0.05 0.87 < 0.001 0.15 < 0.001 0.48 0.01 0.32
Linolenic acid
   T1 99.28 ± 0.89 99.94 ± 0.71 11.42 ± 0.29 10.94 ± 0.17 28.84 ± 0.76 a 33.06 ± 0.36 32.98 ± 0.73 a 31.04 ± 0.76 26.97 ± 0.31 a 27.5 ± 0.34
   T2 100.9 ± 0.89 100.32 ± 0.64 10.94 ± 0.29 10.79 ± 0.15 32.26 ± 0.76 b 32.27 ± 0.32 29.77 ± 0.73 b 29.52 ± 0.69 27.65 ± 0.31 27.7 ± 0.31
   T3 100.02 ± 0.90 99.74 ± 0.68 10.46 ± 0.29 10.93 ± 0.16 36.78 ± 0.77 c 32.09 ± 0.35 27.55 ± 0.74 b 30.13 ± 0.74 28.17 ± 0.31 b 27.48 ± 0.32
   P-value 0.43 0.81 0.06 0.77 < 0.001 0.15 < 0.001 0.36 0.02 0.86
Protein
   T1 100.38 ± 0.89 99.24 ± 0.68 12.04 ± 0.29 a 11.13 ± 0.16 29.47 ± 0.78 a 32.50 ± 0.35 31.56 ± 0.76 29.60 ± 0.74 27.55 ± 0.31 28.27 ± 0.32 a
   T2 101.10 ± 0.88 101.11 ± 0.64 10.62 ± 0.28 b 10.71 ± 0.15 33.07 ± 0.76 b 32.32 ± 0.32 29.81 ± 0.73 30.33 ± 0.69 27.65 ± 0.3 27.49 ± 0.30
   T3 98.68 ± 0.90 99.64 ± 0.66 10.19 ± 0.28 b 10.82 ± 0.16 35.22 ± 0.79 b 32.59 ± 0.33 29.02 ± 0.76 30.70 ± 0.71 27.58 ± 0.31 26.92 ± 031 b
   P-value 0.14 0.10 < 0.001 0.19 < 0.001 0.84 0.05 0.58 0.97 0.10
Riboflavin
   T1 99.77 ± 0.89 99.20 ± 0.67 11.50 ± 0.28 a 10.91 ± 0.16 29.95 ± 0.78 a 32.82 ± 0.34 31.32 ± 0.74 a 29.38 ± 0.72 27.44 ± 0.31 27.96 ± 0.31
   T2 100.76 ± 0.89 100.26 ± 0.64 10.99 ± 0.29 10.73 ± 0.15 32.67 ± 0.78 b 32.21 ± 0.32 30.79 ± 0.74 a 31.33 ± 0.69 27.75 ± 0.31 27.64 ± 0.3
   T3 99.67 ± 0.90 100.56 ± 0.66 10.33 ± 0.29 b 11.01 ± 0.16 35.21 ± 0.79 c 32.38 ± 0.33 28.22 ± 0.75 b 29.93 ± 0.71 27.59 ± 0.31 27.08 ± 0.31
   P-value 0.63 0.34 0.01 0.45 < 0.001 0.42 0.008 0.13 0.78 0.16
Vitamin B6
   T1 101.18 ± 0.89 100.00 ± 0.65 11.83 ± 0.28 a 10.85 ± 0.16 30.29 ± 0.78 a 31.87 ± 0.33 30.67 ± 0.75 29.71 ± 0.71 27.74 ± 0.31 28.26 ± 0.31 a
   T2 99.86 ± 0.90 99.80 ± 0.65 10.56 ± 0.29 b 10.61 ± 0.15 a 34.25 ± 0.79 b 33.00 ± 0.33 30.23 ± 0.75 31.13 ± 0.70 27.77 ± 0.31 27.43 ± 0.31
   T3 99.17 ± 0.88 100.22 ± 0.66 10.43 ± 0.28 b 11.20 ± 0.16 b 34.25 ± 0.78 b 32.55 ± 0.33 29.47 ± 0.75 29.82 ± 0.71 27.27 ± 0.31 26.98 ± 0.31 b
   P-value 0.26 0.90 0.001 0.03 0.001 0.06 0.52 0.29 0.44 0.01
Choline
   T1 100.40 ± 0.90 99.78 ± 0.70 11.63 ± 0.29 a 10.82 ± 0.17 29.26 ± 0.78 a 32.64 ± 0.35 31.80 ± 0.76 a 29.48 ± 0.76 27.44 ± 0.31 28.06 ± 0.33
   T2 100.05 ± 0.89 99.57 ± 0.64 11.12 ± 0.28 a 10.84 ± 0.15 32.83 ± 0.76 b 32.70 ± 0.32 29.58 ± 0.73 29.80 ± 0.68 27.77 ± 0.30 27.73 ± 0.30
   T3 99.76 ± 0.89 100.66 ± 0.67 10.09 ± 0.29 b 10.99 ± 0.16 35.59 ± 0.78 c 32.08 ± 0.34 29.05 ± 0.75 b 31.34 ± 0.72 27.56 ± 0.31 26.92 ± 0.32
   P-value 0.88 0.48 0.001 0.75 < 0.001 0.37 0.02 0.18 0.75 0.05
Vitamin D
   T1 100.37 ± 0.9 100.19 ± 0.66 11.13 ± 0.29 10.76 ± 0.16 32.22 ± 0.79 32.45 ± 0.33 29.52 ± 0.75 29.74 ± 0.71 27.86 ± 0.31 27.75 ± 0.31
   T2 100.00 ± 0.89 99.54 ± 0.64 10.97 ± 0.29 10.93 ± 0.15 33.30 ± 0.79 32.92 ± 0.33 30.60 ± 0.75 31.03 ± 0.70 27.62 ± 0.30 27.53 ± 0.30
   T3 99.81 ± 0.89 100.30 ± 0.64 10.72 ± 0.29 10.96 ± 0.15 31.12 ± 0.79 32.03 ± 0.32 30.28 ± 0.75 29.87 ± 0.69 27.29 ± 0.31 27.41 ± 0.30
   P-value 0.90 0.67 0.60 0.63 0.09 0.16 0.58 0.37 0.43 0.73
Zinc
   T1 100.06 ± 0.88 99.88 ± 0.72 11.47 ± 0.28 a 10.76 ± 0.17 26.86 ± 0.69 a 32.14 ± 0.36 32.88 ± 0.71 a 29.99 ± 0.78 26.86 ± 0.3 a 27.97 ± 0.34
   T2 99.82 ± 0.89 99.53 ± 0.63 11.13 ± 0.28 10.97 ± 0.15 31.66 ± 0.71 b 32.17 ± 0.32 31.56 ± 0.72 a 31.15 ± 0.68 27.60 ± 0.31 27.78 ± 0.30
   T3 100.33 ± 0.90 100.63 ± 0.78 10.21 ± 0.29 b 10.93 ± 0.18 39.56 ± 0.71 c 33.14 ± 0.39 25.77 ± 0.73 b 29.47 ± 0.83 28.34 ± 0.31 b 26.92 ± 0.36
   P-value 0.92 0.56 0.007 0.64 < 0.001 0.15 < 0.001 0.24 0.003 0.14
With diabetes
Carbohydrate
   T1 100.95 ± 1.65 101.73 ± 1.17 10.85 ± 0.53 10.88 ± 0.29 32.08 ± 1.60 33.98 ± 0.61 29.86 ± 1.07 28.61 ± 0.88 27.87 ± 0.62 27.99 ± 0.63
   T2 102.36 ± 1.29 102.09 ± 0.93 10.88 ± 0.4 11.27 ± 0.22 35.78 ± 1.24 33.85 ± 0.47 28.74 ± 0.83 29.81 ± 0.68 28.34 ± 0.47 28.02 ± 0.48
   T3 100.88 ± 1.38 100.77 ± 0.98 11.81 ± 0.44 11.32 ± 0.23 33.47 ± 1.32 34.04 ± 0.50 29.25 ± 0.89 28.99 ± 0.71 28.19 ± 0.50 28.35 ± 0.51
   P-value 0.68 0.62 0.23 0.46 0.16 0.96 0.71 0.54 0.83 0.87
Fiber
   T1 100.09 ± 1.76 102.67 ± 1.4 11.17 ± 0.57 10.85 ± 0.34 26.54 ± 1.53 a 34.16 ± 0.73 33.28 ± 1.04 a 29.54 ± 1.05 27.03 ± 0.65 a 27.63 ± 0.75
   T2 102.22 ± 1.38 102.96 ± 0.98 11.29 ± 0.43 11.05 ± 0.24 32.02 ± 1.17 b 33.76 ± 0.50 30.91 ± 0.79 a 30.07 ± 0.72 27.83 ± 0.49 27.98 ± 0.52
   T3 101.61 ± 1.24 99.79 ± 1.01 11.14 ± 0.40 11.49 ± 0.25 39.54 ± 1.08 c 34.00 ± 0.52 25.69 ± 0.73 b 28.37 ± 0.75 29.01 ± 0.45 b 28.49 ± 0.53
   P-value 0.63 0.10 0.96 0.35 < 0.001 0.88 < 0.001 0.31 0.03 0.69
Linoleic acid
   T1 99.85 ± 1.47 101.13 ± 1.32 11.54 ± 0.46 11.14 ± 0.32 28.05 ± 1.31 a 34.08 ± 0.67 32.07 ± 0.91 a 28.75 ± 0.96 27.17 ± 0.54 a 27.80 ± 0.70
   T2 100.8 ± 1.36 100.40 ± 0.99 11.33 ± 0.44 11.34 ± 0.25 34.43 ± 1.22 b 34.14 ± 0.52 28.68 ± 0.86 b 29.06 ± 0.75 28.14 ± 0.50 28.37 ± 0.53
   T3 103.73 ± 1.40 103.07 ± 1.09 10.76 ± 0.44 11.10 ± 0.26 39.16 ± 1.25 c 33.64 ± 0.56 27.12 ± 0.87 b 29.85 ± 0.80 29.07 ± 0.50 b 28.18 ± 0.57
   P-value 0.13 0.18 0.45 0.76 < 0.001 0.79 < 0.001 0.67 0.03 0.83
Linolenic acid
   T1 99.20 ± 1.40 100.42 ± 1.16 11.53 ± 0.44 11.20 ± 0.28 29.43 ± 1.27 a 34.34 ± 0.59 31.17 ± 0.88 a 28.84 ± 0.85 27.18 ± 0.51 a 27.85 ± 0.61
   T2 102.37 ± 1.37 101.84 ± 0.98 11.02 ± 0.44 11.07 ± 0.24 33.65 ± 1.25 a 33.60 ± 0.50 29.20 ± 0.87 29.04 ± 0.73 28.30 ± 0.50 28.35 ± 0.53
   T3 102.98 ± 1.45 102.39 ± 1.11 11.03 ± 0.46 11.33 ± 0.27 39.56 ± 1.32 b 33.93 ± 0.57 27.03 ± 0.92 b 29.89 ± 0.82 29.08 ± 0.52 b 28.19 ± 0.58
   P-value 0.13 0.52 0.65 0.76 < 0.001 0.66 0.006 0.65 0.03 0.84
Protein
   T1 101.53 ± 1.53 100.49 ± 1.15 12.39 ± 0.48 a 11.58 ± 0.28 29.84 ± 1.45 a 33.52 ± 0.59 31.37 ± 0.98 a 29.50 ± 0.86 28.04 ± 0.56 29.07 ± 0.59
   T2 102.31 ± 1.37 102.58 ± 0.96 10.97 ± 0.42 11.11 ± 0.23 35.28 ± 1.27 b 34.13 ± 0.49 29.09 ± 0.85 29.75 ± 0.71 28.35 ± 0.51 27.93 ± 0.51
   T3 100.64 ± 1.37 101.36 ± 0.98 10.47 ± 0.43 b 10.98 ± 0.23 36.21 ± 1.3 b 34.09 ± 0.50 27.58 ± 0.87 b 28.51 ± 0.72 28.12 ± 0.50 27.56 ± 0.51
   P-value 0.69 0.37 0.01 0.24 0.003 0.71 0.01 0.45 0.90 0.18
Riboflavin
   T1 102.07 ± 1.49 102.00 ± 1.07 11.82 ± 0.45 a 11.32 ± 0.25 30.88 ± 1.39 a 34.29 ± 0.54 30.72 ± 0.94 28.75 ± 0.77 27.94 ± 0.54 28.58 ± 0.55
   T2 102.61 ± 1.49 101.34 ± 1.09 11.81 ± 0.46 a 11.47 ± 0.26 35.51 ± 1.43 34.11 ± 0.56 29.15 ± 0.95 30.03 ± 0.80 28.65 ± 0.54 28.40 ± 0.57
   T3 100.20 ± 1.30 101.33 ± 0.95 10.22 ± 0.41 b 10.89 ± 0.23 35.53 ± 1.25 b 33.55 ± 0.48 28.01 ± 0.84 29.03 ± 0.70 27.99 ± 0.48 27.56 ± 0.49
   P-value 0.43 0.88 0.01 0.24 0.02 0.59 0.10 0.50 0.58 0.36
Vitamin B6
   T1 102.81 ± 1.46 102.32 ± 1.08 12.35 ± 0.44 a 11.63 ± 0.25 a 30.25 ± 1.35 a 33.63 ± 0.54 30.81 ± 0.92 29.1 ± 0.79 27.96 ± 0.53 28.75 ± 0.56
   T2 101.53 ± 1.36 100.78 ± 0.98 10.98 ± 0.42 10.62 ± 0.23 b 37.07 ± 1.27 b 34.38 ± 0.50 28.13 ± 0.86 29.39 ± 0.72 28.77 ± 0.49 28.33 ± 0.51
   T3 100.20 ± 1.30 101.62 ± 1.06 10.24 ± 0.45 b 11.40 ± 0.26 34.52 ± 1.37 33.78 ± 0.55 28.74 ± 0.93 29.20 ± 0.80 27.69 ± 0.54 27.26 ± 0.56
   P-value 0.44 0.58 0.004 0.01 0.001 0.57 0.09 0.96 0.30 0.18
Choline
   T1 102.24 ± 1.57 102.6 ± 1.19 11.88 ± 0.49 a 11.14 ± 0.30 29.85 ± 1.48 a 34.49 ± 0.62 31.44 ± 1 a 28.85 ± 0.9 27.86 ± 0.57 28.67 ± 0.62
   T2 101.27 ± 1.42 99.74 ± 1 11.88 ± 0.43 a 11.2 ± 0.24 33.68 ± 1.29 33.73 ± 0.51 28.86 ± 0.88 28.91 ± 0.74 28.6 ± 0.51 28.91 ± 0.52 a
   T3 101.17 ± 1.3 102.31 ± 0.97 10.09 ± 0.41 b 11.23 ± 0.24 37.35 ± 1.23 b 33.76 ± 0.51 27.93 ± 0.83 b 29.79 ± 0.73 28.04 ± 0.48 27.08 ± 0.51 b
   P-value 0.85 0.1 0.003 0.98 0.001 0.61 0.02 0.66 0.58 0.04
Vitamin D
   T1 102.23 ± 1.43 101.42 ± 1.02 11.8 ± 0.44 11.07 ± 0.25 34.3 ± 1.36 33.59 ± 0.51 28.82 ± 0.91 29.11 ± 0.75 28.58 ± 0.52 28.81 ± 0.53
   T2 101.16 ± 1.47 101.02 ± 1.01 11.15 ± 0.47 11.19 ± 0.25 35.02 ± 1.44 34.58 ± 0.52 29.35 ± 0.96 29.52 ± 0.76 28.28 ± 0.53 28.02 ± 0.53
   T3 101.12 ± 1.36 102.12 ± 0.96 10.67 ± 0.43 11.31 ± 0.23 33.04 ± 1.32 33.74 ± 0.49 29.4 ± 0.87 29.12 ± 0.71 27.7 ± 0.51 27.59 ± 0.51
   P-value 0.82 0.72 0.19 0.79 0.58 0.36 0.88 0.90 0.47 0.26
Zinc
   T1 102.09 ± 1.6 100.53 ± 1.29 12.51 ± 0.5 a 11.31 ± 0.31 28.17 ± 1.39 a 33.47 ± 0.65 32.1 ± 0.95 a 29.71 ± 0.93 27.96 ± 0.58 29.38 ± 0.67
   T2 101.27 ± 1.46 101.93 ± 1.04 11.13 ± 0.44 11.23 ± 0.25 31.75 ± 1.24 a 33.8 ± 0.53 31.24 ± 0.85 a 30.58 ± 0.75 27.62 ± 0.54 27.86 ± 0.55
   T3 101.29 ± 1.26 101.88 ± 1.03 10.43 ± 0.39 b 11.1 ± 0.25 39.68 ± 1.11 b 34.36 ± 0.53 25.76 ± 0.75 b 27.9 ± 0.75 28.7 ± 0.45 27.55 ± 0.53
   P-value 0.91 0.66 0.006 0.89 < 0.001 0.62 < 0.001 0.06 0.28 0.12
Without diabetes
Carbohydrate
   T1 98.4 ± 1.06 98.95 ± 0.79 10.46 ± 0.35 10.59 ± 0.19 30.36 ± 0.91 31.3 ± 0.39 31.81 ± 0.97 31.4 ±0.93 27.11 ± 0.36 27.2 ± 0.36
   T2 99.25 ± 1.19 98.75 ± 0.88 10.88 ± 0.39 10.87 ± 0.21 32.83 ± 1.03 32.08 ± 0.44 29.67 ± 1.09 30 ± 1.03 27.29 ± 0.4 27.17 ± 0.4
   T3 100.43 ± 1.15 99.9 ± 0.86 11.13 ± 0.38 10.73 ± 0.2 32.33 ± 1 31.82 ± 0.43 30.2 ± 1.06 30.62 ± 1.02 27.46 ± 0.39 27.41 ± 0.39
   P-value 0.43 0.6 0.42 0.63 0.15 0.41 0.3 0.6 0.81 0.89
Fiber
   T1 99.52 ± 1.05 99.68 ± 0.9 11.08 ± 0.34 10.66 ± 0.21 26.85 ± 0.82 a 31.16 ± 0.45 32.98 ± 0.94 a 29.05 ± 1.06 26.8 ± 0.35 27.75 ± 0.4
   T2 98.41 ± 1.14 97.99 ± 0.86 10.91 ± 0.37 10.85 ± 0.2 31.69 ± 0.89 b 31.81 ± 0.43 31.67 ± 1.02 a 32.35 ± 1.01 27.21 ± 0.38 27.16 ± 0.39
   T3 100.12 ± 1.23 99.89 ± 1.11 10.31 ± 0.4 10.67 ± 0.26 38.64 ± 0.96 c 32.32 ± 0.56 26.25 ± 1.1 b 31.15 ± 1.3 28.04 ± 0.41 26.69 ± 0.5
   P-value 0.57 0.25 0.33 0.77 < 0.001 0.35 < 0.001 0.08 0.70 0.33
Linoleic Acid
   T1 98.77 ± 1.13 99.83 ± 0.89 10.96 ± 0.37 10.88 ± 0.21 28.24 ± 0.94 a 32.04 ± 0.45 33.94 ± 1.01 a 31.56 ± 1.05 26.65 ± 0.38 27.08 ± 0.4
   T2 100.42 ± 1.15 98.55 ± 0.9 11.29 ± 0.37 10.45 ± 0.21 32.43 ± 0.97 b 31.98 ± 0.45 29.49 ± 1.05 b 29.97 ± 1.06 27.67 ± 0.39 27.77 ± 0.4
   T3 98.83 ± 1.11 99.14 ± 0.85 10.19 ± 0.36 10.82 ± 0.2 34.72 ± 0.94 b 31.11 ± 0.43 28.44 ± 1.01 b 30.58 ± 1 27.54 ± 0.37 26.96 ± 0.38
   P-value 0.51 0.63 0.1 0.31 < 0.001 0.25 < 0.001 0.59 0.12 0.3
Linolenic acid
   T1 99.34 ± 1.14 99.6 ± 0.91 11.34 ± 0.37 10.76 ± 0.21 28.46 ± 0.95 a 32.32 ± 0.45 34.02 ± 1.02 a 32.17 ± 1.07 26.83 ± 0.38 27.41 ± 0.41
   T2 100.09 ± 1.14 99.49 ± 0.85 10.9 ± 0.37 10.64 ± 0.2 31.51 ± 0.95 a 31.64 ± 0.42 30.08 ± 1.02 b 29.8 ± 0.99 27.29 ± 0.38 27.34 ± 0.38
   T3 98.55 ± 1.12 98.5 ± 0.87 10.18 ± 0.37 10.77 ± 0.21 35.39 ± 0.95 b 31.16 ± 0.44 27.84 ± 1.02 b 30.27 ± 1.03 27.7 ± 0.38 27.03 ± 0.39
   P-value 0.63 0.64 0.08 0.89 < 0.001 0.22 < 0.001 0.26 0.27 0.79
Protein
   T1 99.72 ± 1.09 98.49 ± 0.85 11.81 ± 0.36 a 10.87 ± 0.2 29.25 ± 0.94 a 31.92 ± 0.43 31.66 ± 1.02 29.76 ± 1.01 27.27 ± 0.37 27.83 ± 0.38
   T2 100.37 ± 1.13 100.47 ± 0.85 10.43 ± 0.36 b 10.51 ± 0.2 31.74 ± 0.95 31.38 ± 0.42 30.27 ± 1.04 30.64 ± 0.99 27.26 ± 0.38 27.23 ± 0.38
   T3 97.74 ± 1.17 98.65 ± 0.89 10.09 ± 0.37 b 10.79 ± 0.21 34.70 ± 0.99 b 31.80 ± 0.44 29.88 ± 1.07 31.89 ± 1.04 27.31 ± 0.40 26.64 ± 0.40
   P-value 0.25 0.19 0.002 0.42 < 0.001 0.64 0.44 0.36 0.99 0.12
Riboflavin
   T1 98.97 ± 1.11 97.83 ± 0.85 11.42 ± 0.36 10.65 ± 0.20 29.53 ± 0.94 a 32.00 ± 0.43 31.63 ± 1.01 29.70 ± 1.01 27.27 ± 0.37 27.64 ± 0.39
   T2 99.76 ± 1.1 99.62 ± 0.81 10.54 ± 0.36 10.41 ± 0.19 a 31.41 ± 0.93 a 31.30 ± 0.41 31.53 ± 1.01 31.90 ± 0.95 27.27 ± 0.37 27.13 ± 0.37
   T3 99.21 ± 1.20 100.25 ± 0.92 10.40 ± 0.39 11.17 ± 0.21 b 34.91 ± 1.02 b 31.84 ± 0.46 28.40 ± 1.10 30.50 ± 1.08 27.31 ± 0.41 26.97 ± 0.42
   P-value 0.87 0.14 0.11 0.03 0.001 0.45 0.05 0.27 0.99 0.49
Vitamin B6
   T1 100.43 ± 1.10 98.93 ± 0.84 11.58 ± 0.36 10.45 ± 0.20 30.31 ± 0.96 30.88 ± 0.42 30.60 ± 1.02 30.06 ± 0.99 27.64 ± 0.37 28.03 ± 0.37
   T2 98.85 ± 1.17 99.43 ± 0.88 10.31 ± 0.38 10.68 ± 0.20 32.59 ± 1.00 32.35 ± 0.43 31.47 ± 1.07 31.99 ± 1.02 27.14 ± 0.39 26.86 ± 0.39
   T3 98.6 ± 1.12 99.24 ± 0.84 10.48 ± 0.36 11.04 ± 0.20 32.57 ± 0.97 31.92 ± 0.42 29.9 ± 1.03 30.22 ± 0.99 27.04 ± 0.38 26.83 ± 0.38
   P-value 0.45 0.91 0.03 0.12 0.16 0.05 0.57 0.34 0.48 0.04
Choline
   T1 99.5 ± 1.09 98.48 ± 0.87 11.45 ± 0.36 a 10.62 ± 0.21 28.98 ± 0.93 a 31.80 ± 0.44 31.97 ± 1.01 29.84 ± 1.03 27.2 ± 0.37 27.60 ± 0.39
   T2 99.37 ± 1.12 99.42 ± 0.83 10.72 ± 0.36 10.68 ± 0.19 32.30 ± 0.94 b 32.06 ± 0.41 30.01 ± 1.02 30.42 ± 0.97 27.34 ± 0.38 27.14 ± 0.37
   T3 99.05 ± 1.20 99.75 ± 0.92 10.15 ± 0.39 b 10.89 ± 0.21 34.50 ± 1.01 b 31.20 ± 0.46 29.80 ± 1.09 32.06 ± 1.08 27.31 ± 0.4 26.99 ± 0.41
   P-value 0.96 0.61 0.04 0.66 < 0.001 0.38 0.26 0.34 0.96 0.57
Vitamin D
   T1 99.36 ± 1.14 99.42 ± 0.87 10.78 ± 0.37 10.54 ± 0.20 32.56 ± 0.98 31.83 ± 0.44 29.94 ± 1.04 30.16 ± 1.02 27.47 ± 0.39 27.15 ± 0.39
   T2 99.50 ± 1.11 99.82 ± 0.83 10.87 ± 0.36 10.83 ± 0.20 32.53 ± 0.96 32.03 ± 0.42 31.22 ± 1.02 31.71 ± 0.98 27.3 ± 0.37 27.31 ± 0.38
   T3 99.05 ± 1.15 99.37 ± 0.85 10.75 ± 0.38 10.79 ± 0.20 30.03 ± 0.99 31.22 ± 0.43 30.78 ± 1.06 30.24 ± 1.01 27.06 ± 0.38 27.30 ± 0.39
   P-value 0.96 0.86 0.97 0.58 0.11 0.37 0.67 0.48 0.76 0.95
Zinc
   T1 99.17 ± 1.06 99.49 ± 0.89 11.02 ± 0.35 10.53 ± 0.21 26.33 ± 0.81 a 31.51 ± 0.44 33.19 ± 0.95 a 30.02 ± 1.05 26.39 ± 0.35 a 27.22 ± 0.40
   T2 99.13 ± 1.12 98.35 ± 0.81 11.13 ± 0.36 10.82 ± 0.19 31.62 ± 0.85 b 31.26 ± 0.40 31.71 ± 0.99 a 31.67 ± 0.96 27.59 ± 0.37 27.66 ± 0.37
   T3 99.77 ± 1.25 99.86 ± 1.11 10.10 ± 0.40 10.86 ± 0.26 39.51 ± 0.94 c 32.52 ± 0.55 25.80 ± 1.11 b 30.48 ± 1.30 28.12 ± 0.41 b 26.81 ± 0.50
   P-value 0.91 0.43 0.12 0.54 < 0.001 0.20 < 0.001 0.45 0.005 0.36
a, ,b, c: Values with different superscripts were significantly different. (P <0.05); d: ANCOVA was used. Bonferroni was used for multiple comparisons; e:  Data are presented as mean ± SE ANCOVA was used. Bonferroni was used for multiple comparisons; f: Adjusted for age, energy, sex, married status, menopausal status, physical activity, economic status, job, educational level, smoking, drug addiction, diabetes, and body mass index.

Conflicts of interest
The authors declared no conflicts of interest.
Funding
This study was financially supported by Shahid Sadoughi University of Medical Sciences (no.IR.SSU.SPH.REC.1403.057).
References
Abbas Torki S, et al. 2022. Association between the index of nutritional quality and lipid profile in adult women. Endocrinol diabetes metab. 5 (5): e358.
Aboyans V & Causes of Death Collaborators 2015. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 385 (9963): 117-171.
Ades P & Savage P 2017. Obesity in coronary heart disease: An unaddressed behavioral risk factor. Preventive medicine. 104: 117-119.
Alami F, et al. 2022. The association between fasting blood sugar and Index of nutritional quality in adult women. Frontiers in nutrition. 9: 883672.
Alexander R 1995. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension. 25 (2): 155-161.
Anand S, et al. 2015. Food consumption and its impact on cardiovascular disease: importance of solutions focused on the globalized food system: A report from the workshop convened by the world heart federation. Journal of the American College of Cardiology. 66 (14): 1590-1614.
Arabi V, et al. 2024. Medicinal herbs consumption in relation to cardiometabolic indices and coronary artery stenosis in participants undergoing coronary angiography: A cross-sectional study. Phytotherapy research. 38 (10): 4999-5015.
Arnett D, et al. 2019. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 140 (11): e596-e646.
Ashoori M & Saedisomeolia A 2014. Riboflavin (vitamin B2) and oxidative stress: a review. British journal of nutrition. 111 (11): 1985-1991.
Bartley GE, et al. 2010. Hypocholesterolemic effects of hydroxypropyl methylcellulose are mediated by altered gene expression in hepatic bile and cholesterol pathways of male hamsters. Journal of nutrition. 140 (7): 1255-1260.
Bechthold A, et al. 2019. Food groups and risk of coronary heart disease, stroke and heart failure: A systematic review and dose-response meta-analysis of prospective studies. Critical reviews in food science and nutrition. 59 (7): 1071-1090.
Berryman CE, Lieberman HR, Fulgoni III VL & Pasiakos SM 2021. Greater protein intake at breakfast or as snacks and less at dinner is associated with cardiometabolic health in adults. Clinical nutrition. 40 (6): 4301-4308.
Chang T-Y, et al. 2022. Optimal dietary intake composition of choline and betaine is associated with minimized visceral obesity-related hepatic steatosis in a case-control study. Nutrients. 14 (2): 261.
Clifton PM, Bastiaans K & Keogh JB 2009. High protein diets decrease total and abdominal fat and improve CVD risk profile in overweight and obese men and women with elevated triacylglycerol. Nutrition, metabolism and cardiovascular diseases. 19 (8): 548-554.
Coulston A 2001. The search continues for a tool to evaluate dietary quality. American journal of clinical nutrition. 74 (4): 417.
Dalen J, Alpert J, Goldberg R & Weinstein R 2014. The epidemic of the 20(th) century: coronary heart disease. American journal of medicine. 127 (9): 807-812.
Daneshzad E, Larijani B & Azadbakht L 2019. Diet quality indices and cardiovascular diseases risk factors among diabetic women. Journal of the science of food and agriculture. 99 (13): 5926-5933.
DiNicolantonio J & OKeefe J 2017. Added sugars drive coronary heart disease via insulin resistance and hyperinsulinaemia: a new paradigm. Open heart. 4 (2): e000729.
Dziedzic EA, Przychodzeń S & Dąbrowski M 2016. The effects of vitamin D on severity of coronary artery atherosclerosis and lipid profile of cardiac patients. Archives of medical science. 12 (6): 1199-1206.
Emdadi R, et al. 2016. Prevalence of vitamin D deficiency among women of reproductive age: A multi centric study in Tehran. Shiraz E-medical journal. 17 (11): e40745.
Forsythe WA, Green MS & Anderson J 1986. Dietary protein effects on cholesterol and lipoprotein concentrations: a review. Journal of the American College of Nutrition. 5 (6): 533-549.
Fu L, Zhang G, Qian S, Zhang Q & Tan M 2022. Associations between dietary fiber intake and cardiovascular risk factors: An umbrella review of meta-analyses of randomized controlled trials. Frontiers in nutrition. 9: 972399.
Gao X, et al. 2016. Higher dietary choline and betaine intakes are associated with better body composition in the adult population of Newfoundland, Canada. PloS one. 11 (5): e0155403.
Gardner CD, et al. 2007. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA. 297 (9): 969-977.
Gholamalizadeh M, et al. 2021. Index of nutritional quality (INQ) and the risk of obesity in male adolescents: a case-control study. Biological trace element research. 199 (5): 1701-1706.
Hagiwara S, et al. 2009. Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice. Metabolism. 58 (7): 934-945.
Haidari F, Mohammadshahi M, Zarei M, Haghighizadeh M & Mirzaee F 2021. The effect of pyridoxine hydrochloride supplementation on leptin, adiponectin, glycemic indices, and anthropometric indices in obese and overweight women. Clinical nutrition research. 10 (3): 230-242.
Hajar R 2017. Risk factors for coronary artery disease: historical perspectives. Heart views. 18 (3): 109-114.
Harripersad R & Burger F 1997. The effect of a subnormal dose of vitamin B6 on plasma lipid in the rat. International journal for vitamin and nutrition research. . 67 (2): 95-101.
Hlais S, et al. 2012. Effect of lysine, vitamin B6, and carnitine supplementation on the lipid profile of male patients with hypertriglyceridemia: a 12-week, open-label, randomized, placebo-controlled trial. Clinical therapeutics. 34 (8): 1674-1682.
Huang J, Tian L, Wu X, Yang H & Liu Y 2010. Effects of dietary riboflavin levels on antioxidant defense of the juvenile grouper Epinephelus coioides. Fish physiology and biochemistry. 36: 55-62.
Huang X, Yang Y, Jiang Y, Zhou Z & Zhang J 2023. Association between vitamin D deficiency and lipid profiles in overweight and obese adults: a systematic review and meta-analysis. BMC public health. 23 (1): 1653.
Jalali M, et al. 2022. The association between index of nutritional quality (INQ) and obesity: Baseline data of Kharameh Cohort. BioMed research international 2022: 8321596.
Jasemi SV, et al. 2023. Is vitamin D supplementation program in Iranian schools effective in reducing adolescent depressive symptoms? Cost effectiveness study. BMC public health. 23 (1): 1393.
Jayedi A & Zargar MS 2019. Intake of vitamin B6, folate, and vitamin B12 and risk of coronary heart disease: a systematic review and dose-response meta-analysis of prospective cohort studies. Critical reviews in food science and nutrition. 59 (16): 2697-2707.
Jo U & Park K 2023. Carbohydrate intake and risk of cardiovascular disease: A systematic review and meta-analysis of prospective studies. Nutrients. 15 (7).
Konstantinova S, et al. 2008. Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. Journal of nutrition. 138 (5): 914-920.
Layman DK, et al. 2009. A moderate-protein diet produces sustained weight loss and long-term changes in body composition and blood lipids in obese adults. Journal of nutrition. 139 (3): 514-521.
Li J, Huang J, Lv Y & Ji H 2023. Association between dietary intakes of B vitamins and nonalcoholic fatty liver disease in postmenopausal women: a cross-sectional study. Frontiers in nutrition. 10: 1272321.
Li S, et al. 2016. Increase of circulating cholesterol in vitamin D deficiency is linked to reduced vitamin D receptor activity via the Insig‐2/SREBP‐2 pathway. Molecular nutrition & food research. 60 (4): 798-809.
Lupton JR, et al. 2016. Deficient serum 25-hydroxyvitamin D is associated with an atherogenic lipid profile: The Very Large Database of Lipids (VLDL-3) study. Journal of clinical lipidology. 10 (1): 72-81. e71.
Malakar A, et al. 2019. A review on coronary artery disease, its risk factors, and therapeutics. Journal of cellular physiology. 234 (10): 16812-16823.
Mohamadi A, et al. 2023. The association between adherence to diet quality index and cardiometabolic risk factors in overweight and obese women: a cross-sectional study. Front public health. 11: 1169398.
Mohammadifard N, Mansourian M, Firouzi S, Taheri M & Haghighatdoost F 2022. Longitudinal association of dietary carbohydrate and the risk cardiovascular disease: a dose-response meta-analysis. Critical reviews in food science and nutrition. 62 (23): 6277-6292.
Mons U, et al. 2015. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. British medical journal. 350: h1551.
Motallaei M, et al. 2023. A cross-sectional study on the association between lifestyle factors and coronary artery stenosis severity among adults living in central Iran: A protocol for the Iranian- CARDIO study. ARYA atherosclerosis journal. 20 (1): 51.
Mozaffarian D, et al. 2015. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 131 (4): e29-322.
Mozaffarian D, Katan M, Ascherio A, Stampfer M & Willett W 2006. Trans fatty acids and cardiovascular disease. New England journal of medicine. 354 (15): 1601-1613.
Naghshi S, et al. 2021. Dietary intake and biomarkers of alpha linolenic acid and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of cohort studies. British medical journal. 375.
Naghshi S, Sadeghi O, Willett WC & Esmaillzadeh A 2020. Dietary intake of total, animal, and plant proteins and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of prospective cohort studies. British medical journal. 370: m2412.
Narain A, Kwok C & Mamas M 2016. Soft drinks and sweetened beverages and the risk of cardiovascular disease and mortality: a systematic review and meta-analysis. International journal of clinical practice. 70 (10): 791-805.
Neeland I, et al. 2012. Coronary angiographic scoring systems: an evaluation of their equivalence and validity. American heart journal 164 (4): 547-552.e541.
Pate R, et al. 1995. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 273 (5): 402-407.
Pencina M, et al. 2019. Quantifying importance of major risk factors for coronary heart disease. Circulation. 139 (13): 1603-1611.
Pereira MA, et al. 2004. Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Archives of internal medicine. 164 (4): 370-376.
Perk J, et al. 2012. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). European heart journal. 33 (13): 1635-1701.
Pregnolato P, et al. 1994. Interaction among dietary vitamin B6, proteins and lipids: effects on liver lipids in rats. International journal for vitamin and nutrition research. 64 (4): 263-269.
Qi X & Shen P 2020. Associations of dietary protein intake with all-cause, cardiovascular disease, and cancer mortality: A systematic review and meta-analysis of cohort studies. Nutrition, metabolism & cardiovascular diseases. 30 (7): 1094-1105.
Santesso N, et al. 2012. Effects of higher-versus lower-protein diets on health outcomes: a systematic review and meta-analysis. European journal of clinical nutrition. 66 (7): 780-788.
Sepandi M, Parastouei K & Samadi M 2022. Diet quality indices in relation to cardiovascular risk factors in T2DM patients: A systematic review. International journal of preventive medicine. 13: 106.
Shin W-y & Kim J-h 2019. Low riboflavin intake is associated with cardiometabolic risks in Korean women. Asia Pacific journal of clinical nutrition. 28 (2): 285-299.
Sivanesan S, Taylor A, Zhang J & Bakovic M 2018. Betaine and choline improve lipid homeostasis in obesity by participation in mitochondrial oxidative demethylation. Frontiers in nutrition. 5: 61.
Sorenson A, Wyse B, Wittwer A & Hansen R 1976. An index of nutritional quality for a balanced diet. New help for an old problem. Journal of the American Dietetic Association. 68 (3): 236-242.
Surdu AM, et al. 2021. Vitamin D and its role in the lipid metabolism and the development of atherosclerosis. Biomedicines. 9 (2): 172.
Threapleton D, et al. 2013. Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. British medical journal. 347: f6879.
USDA 2018. USDA food composition databases. USDA Washington (DC).
Wang G, Li W, Lu X & Zhao X 2011. Riboflavin alleviates cardiac failure in Type I diabetic cardiomyopathy. Heart international. 6 (2): hi. 2011. e2021.
Wang J, et al. 2003. Comparisons of waist circumferences measured at 4 sites. American journal of clinical nutrition. 77 (2): 379-384.
Wen H, et al. 2023. Association of vitamin B1 with cardiovascular diseases, all-cause and cardiovascular mortality in US adults. Frontiers in nutrition. 10: 1175961.
Wu Y, et al. 2015. Association between dietary fiber intake and risk of coronary heart disease: A meta-analysis. Clinical nutrition. 34 (4): 603-611.
Yang X, et al. 2016. Predicting the 10-year risks of atherosclerotic cardiovascular disease in chinese population: The china-PAR project (Prediction for ASCVD Risk in China). Circulation. 134 (19): 1430-1440.
Yuan Q, et al. 2022. The review of alpha‐linolenic acid: Sources, metabolism, and pharmacology. Phytotherapy research. 36 (1): 164-188.
Yue H, et al. 2021. Effects of α-linolenic acid intake on blood lipid profiles a systematic review and meta-analysis of randomized controlled trials. Critical reviews in food Science and nutrition. 61 (17): 2894-2910.
Yusuf S, et al. 2004. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 364 (9438): 937-952.
Zhong R-h, et al. 2020. Association between serum choline and betaine concentrations and longitudinal changes of body composition in community-dwelling middle-aged and older Chinese adults. Applied physiology, nutrition, and metabolism. 45 (7): 737-744.
Zhou R, et al. 2023. Association between dietary choline intake and cardiovascular diseases: National health and nutrition examination survey 2011-2016. Nutrients. 15 (18).
Zimorovat A, et al. 2022a. Validity and reproducibility of a semiquantitative multiple-choice food frequency questionnaire in Iranian adults. Food and nutrition bulletin. 43 (2): 171-188.
Zimorovat A, et al. 2022b. Validity and reproducibility of a semiquantitative multiple-choice food frequency questionnaire in Iranian adults. Food and nutrition bulletin. 43 (2): 171-188.

Type of article: orginal article | Subject: public specific
Received: 2025/04/6 | Published: 2026/02/21 | ePublished: 2026/02/21

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 3.0 | Journal of Nutrition and Food Security

Designed & Developed by : Yektaweb